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Like most major enzyme families, the M14 family of metallocarboxypeptidases 
(MCPs) contains several pseudoenzymes predicted to lack enzyme activity and with 
unknown molecular function. The genome of the yeast Saccharomyces cerevisiae encodes 
only one member of the M14 MCP family, a pseudoenzyme named Ecm14 proposed to 
function in the extracellular matrix. Ecm14 is found throughout ascomycete fungi, with a 
group of related pseudoenzymes found in basidiomycetes. Although the prodomain of 
Ecm14 can be cleaved in vivo and in vitro by endopeptidases, suggesting an activation 
mechanism, no activity has been detected using standard carboxypeptidase substrates.  
In order to examine the function of Ecm14 using an unbiased screen, a series of 
synthetic lethal assays were performed. Because biochemical pathways typically involve 
multiple key gene components, many of these key gene players provide redundancy if other 
genes experience deleterious mutations. The synthetic lethal screen identifies novel 
mutants whose survival depends on a particular gene of interest. Approximately 27,000 
yeast colonies were screened; however, only twenty-two putative ecm14 synthetic lethal 
mutants were identified. Further analysis showed many to be synthetic lethal with 
auxotrophic marker (plasmid reporting and selection) genes and synthetic lethality due to 
multiple mutations, suggesting that there are few, if any, single S. cerevisiae genes that 
present synthetic lethal interactions with ecm14. Recent research by others suggests a role 
for Ecm14 in processes such as vesicle-mediated transport and aggregate invasion, a fungal 
process that has been selected against in modern laboratory strains of S. cerevisiae. Thus, 
Ecm14 is likely an important, conserved, and “activatable” component of extracellular 
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Genomes and the Evolution of Pseudoenzymes 
Genomes contain a variety of components encoded in the ubiquitous four-base 
language of nucleic acids. Although genes have traditionally been defined by their ability 
to direct the translation of protein, many genes fundamentally lack all protein-coding 
ability. These non-coding pseudogenes were once thought to be “junk DNA.” However, 
numerous investigations have demonstrated that these non-coding DNA sequences indeed 
play critical roles in directing protein synthesis and regulating gene expression through 
their RNA products. Notable examples of these ubiquitous non-coding RNAs include 
ribosomal RNA (rRNA), transfer RNA (tRNA), and microRNA (Pink et al., 2011).  
Other genes, though coding for proteins, may not actually encode for the functions 
that might be predicted based solely on their homology with other known and annotated 
sequences. Although key active site substitutions in what appear to be enzyme-coding 
genes might suggest a loss of catalytic activity, these substitutions might instead point 
towards either a presently unknown and uncharacterized substrate or some novel 
biochemical process. 
It has been suggested that all major enzyme families across all kingdoms of life 
likely contain inactive enzyme-homologues (Adrain & Freeman, 2012; Eyers & Murphy, 
2016; Kwon et al., 2019; Ribeiro et al., 2019). In general, these pseudoenzymes are 
characterized by highly conserved domains that appear structurally like those domains 
found in otherwise catalytically active enzymes. However, substitutions of key active site 
amino acids (or the absence of entire catalytic motifs altogether) in these conserved 
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domains suggest a loss of expected function in pseudoenzymes. From an evolutionary 
perspective, enzymes might evolve an altered substrate specificity, an altered reaction to 
be catalyzed, or, as in the extreme case of pseudoenzymes, a complete loss of catalytic 
activity. However, the inclusion of these pseudoenzymes in our present understanding of 
signal transduction networks and regulatory pathways is still relatively new and emerging 
within the current paradigm of systems biology. Thus, pseudoenzymes have only recently 
been considered as possible key players (Eyers & Murphy, 2016). In general, much work 
remains in understanding these ubiquitous pseudoenzymes and evaluating their usefulness 
as potential targets (or anti-targets) in the development of novel therapeutic agents. 
The two most well documented pseudoenzymes are of the kinase and phosphatase 
families (Eyers & Murphy, 2013; Reiterer et al., 2014). [In general, kinases attach 
phosphate groups and phosphatases remove phosphate groups.] These inactive enzyme-
homologues have been demonstrated to function both as allosteric modulators (either by 
activation or inhibition) and as non-catalytic competitors in signal transduction pathways 
(Eyers & Murphy, 2016). Therefore, the present evidence suggests that pseudoenzymes are 
likely functional, not as catalytically active enzymes, but rather as binding proteins that 
only transiently interact with their substrates.  
The central hypothesis for understanding the evolution of pseudoenzymes first 
involves the genomic duplication of an “active” ancestral enzyme open reading frame 
followed by subsequent mutation events that, while off-selection, can repurpose a domain 
found in otherwise catalytically active enzyme (see Figure 1). These genetic copies, 
though being functionally redundant, lack the traditional evolutionary pressure required to 
maintain the otherwise catalytic motifs and phenotype(s) of their ancestral enzyme and, 
3 
thus, allow these genes to accumulate novel mutations (Bergthorsson et al., 2007; Eyers & 
Murphy, 2016; Ohno, 1970). 
 
 
Figure 1. The evolution of pseudoenzymes from active enzyme-homologues. 
The evolution of pseudoenzymes might first (1) involves the genomic duplication 
of an ‘active’ ancestral enzyme open reading frame followed by (2) subsequent 
mutation events that, in turn, repurpose a domain found in otherwise catalytically 
active enzyme in some potentially novel role. 
 
The two primary models for understanding how genes (and, thus by proxy, their 
protein or enzyme products) evolve novel functions through this broad mechanism of gene 
duplication are 1) neofunctionalization and 2) subfunctionalization (Force et al., 1999; 
Noda-Garcia & Barona-Gomez, 2013; Ohno, 1970). The accumulation of mutation events 
in a duplicated gene over time typically results in the ubiquitous non-coding pseudogenes. 
However, a divergence of function can occur when mutations either give rise to a novel 
function or cause an otherwise promiscuous ancestral enzyme (one with several distinct 
sub-functions) to further refine and specialize on a sub-function. 
Catalytic motifs are defined in part by the presence of specific active site residues 
that catalyze some specific biochemical reaction(s). However, these motifs are also defined 
by their ability to interact with very specific ligands in potentially non-catalytic ways. 
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Reiterer et al. (2014) suggested that at least some active enzymes might have paradoxically 
evolved from pseudoenzymes. However, in the absence of selective pressures to maintain 
the catalytic motif in these duplicated genes, evolution is allowed to further tweak the non-
catalytic function of these pseudoenzymes and, in turn, cause their sequences to further 
deviate over time from their original ancestral sequences. 
Although previous investigations involving pseudoenzymes have suggested 
possible non-catalytic functions, it has been suggested that even catalytically active 
enzymes too might be able to perform these novel, unexpected secondary functions (so-
called promiscuous or “moonlighting” enzymes) (Jeffery, 2003). Therefore, both active 
enzymes and their inactive homologues might share these previously uncharacterized and 
noncatalytic roles. Because the structural motifs of active enzymes are inherently 
predisposed to facilitating very specific substrate-binding interactions, these structures 
serve as ideal candidates to being evolutionarily repurposed and reused in some non-
catalytic capacity (Eyers & Murphy, 2016). Therefore, studies involving pseudoenzymes 
can potentially inform our understanding of even catalytically active enzymes in general 
by suggesting possible functions beyond just the prototypical native catalytic function. 
One possible model for understanding the function of pseudoenzymes that have 
been implicated in substrate binding and localization is the rhomboid protease family, 
which includes several active members as well as inactive enzyme-homologues. [Proteases 
and proteolysis are discussed in more detail in a subsequent introductory section.] Active 
rhomboid proteases function in the proteolysis of transmembrane proteins and the 
subsequent release of signaling molecules from a variety of cellular organelles (Lemberg, 
2011). Active rhomboid proteases have been demonstrated to function in the epidermal 
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growth factor receptor signaling pathway in C. elegans, Drosophila, and mammalian cells 
(Adrain & Freeman, 2012; Blobel et al., 2009; Dutt et al., 2004).These active proteases cut 
membrane-bound growth factor precursors and liberate active growth factors which in turn 
bind to receptors on neighboring cells and initiate cascades of growth signals. In contrast, 
several inactive rhomboid pseudoproteases (e.g. Derlin-1 and iRhoms) have adopted novel, 
non-traditional function that seem to complement the function of active rhomboid 
proteases: they bind to and help destabilize substrate proteins targeted by active rhomboid 
proteases in the endoplasmic reticulum-associated degradation of misfolded proteins 
(Adrain & Freeman, 2012; Greenblatt et al., 2011; Zettl et al., 2011).   
How these pseudoenzymes adapt and evolve to fill novel biological and 
biochemical niches in general remains to be fully understood. The broad classification of 
putative pseudoenzymes is largely based on batch in silico sequence comparisons against 
sequences of known catalytic domains that have a wealth of experimental validation in the 
literature. In other words, such comparisons only work well when using catalytic source 
sequences with very well-defined mutations that demonstrably nullify the expected 
catalytic activity. However, this type of comparison does suggest probable knowledge gaps 
and the inescapable possibility that many enzymes are actually erroneously classified as 
catalytically active in online enzyme databases (or, conversely, many pseudoenzymes 
incorrectly classified as catalytically inactive) due to a fundamental lack of targeted 
experimental evidence (Eyers & Murphy, 2016; Ribeiro et al., 2019). 
Because pseudoenzymes are thought to be present in all major enzyme families 
across all domains of life, the majority of these pseudoenzymes largely remain either 
unidentified, misidentified, or entirely uncharacterized. For instance, adequately validating 
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a complete lack of catalytic function fundamentally requires that all possible substrates be 
known—a lofty and seemingly insurmountable requirement (Ribeiro et al., 2019). 
Furthermore, the obscure functional nature of these pseudoenzymes makes them inherently 
difficult to associate with a phenotype. However, a quantifiable phenotype is 
fundamentally needed in order to systematically study the biochemical and biological 
implications of the key active site substitutions found in these pseudoenzymes. Once a 
quantifiable phenotype is either identified or engineered, a series of targeted experiments 
can be performed that selectively interrogate each of the key active site substitutions and 
individually assess their necessity and/or usefulness. One goal of this study is to design 
such a targeted approach to the investigation of a suspected pseudoenzyme found in the 
baker’s yeast Saccharomyces cerevisiae.   
 Although targeted experiments focused on the biochemical and biological nature 
of pseudoenzymes remain to be particularly challenging, there are several key strategies 
and techniques that can be used to build a general case for function (or the lack thereof). 
These strategies might include sequence comparison and protein homology modeling, 
classifying and grouping novel genes as being involved in broad functional classes, 
phylogenic tree analysis and visualization, enzymatic prodomain cleavage followed by 
Edman N-terminal degradation sequencing, enzyme activity assays, and in vivo protein 
localization and gene expression assays.  
Although prior investigations have demonstrated that several pseudoenzymes have 
also adopted novel, non-catalytic functions, much work remains in order to accurately 
identify, clarify and characterize the function of these inactive enzyme-homologous 
(Greenblatt et al., 2011; Pils & Schultz, 2004; Zettl et al., 2011). 
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Saccharomyces cerevisiae as a Model Organism  
One flexible model organism for studying the biochemical and biological nature of 
pseudoenzymes is the ascomycete fungi Saccharomyces cerevisiae (see Figure 2). 
Because the yeast S. cerevisiae has an extensive history both as a model organism and in 
the baking and brewing industries, many well-demonstrated techniques and tools already 
exist that make its genetic manipulation both inexpensive and robust.  
 
Figure 2. A budding haploid S. cerevisiae yeast cell. 
A micrograph of a budding haploid S. cerevisiae yeast cell. The large central 
vacuole in the parent yeast cell can be observed poking into the daughter bud. 
 
As a eukaryotic organism, yeast are capable of reproducing sexually and exhibit an 
alternation of generations between diploid, spore-producing sporophytes and haploid, 
gamete-producing gametophytes. Additionally, humans and yeast share over one thousand 
orthologous genes (~23% homologous genes to humans) (Laurent et al., 2016; Liu et al., 
2017). Therefore, these features together make the yeast S. cerevisiae a prime candidate 
for high-throughput gene function studies that require both precise genetic manipulation 
and sexual reproduction capabilities (qualities that are of critical importance to this 
investigation in particular). 
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Yeast have considerably simpler genomes than those of higher order eukaryotes. 
Like bacteria, yeast can readily be transformed with plasmid DNA (Hinnen et al., 1978). 
These plasmids can either replicate independently (sometimes even behaving like 
miniature chromosomes) or integrate directly into the yeast genome, sometimes tagging or 
even deleting endogenous genes via homologous recombination (Duina et al., 2014). The 
capability to selectively target, tag, and disrupt endogenous genes with a high degree of 
precision has made yeast a preeminent model organism. Furthermore, the sophisticated 
portfolio of genomic and molecular tools available to yeast biologists further qualify S. 
cerevisiae as a premier experimental subject. 
Chromosome III (315-kb) of the yeast S. cerevisiae genome was the first 
chromosome from any organism to be completely sequenced (Oliver et al., 1992). In 
addition to the monumental achievements related to chromosome III, the prevalence of S. 
cerevisiae in both commercial industry and human health likely motivated the worldwide 
collaboration to sequence the remaining 15 chromosomes (Goffeau et al., 1996). As such, 
the yeast genome was the first eukaryotic genome to be entirely sequenced. To date, the 
yeast genome has been thoroughly sequenced many times over, using every major 
generation of whole-genome sequencing technology including Sanger, Illumina®, 
PacBio®, and Oxford Nanopore® (Cherry et al., 2012; Engel et al., 2014; Goodwin et al., 
2015; Matheson et al., 2017).The Saccharomyces Genome Database (SGD) is the 
prominent, online database and curated search tool for exploring the wealth of yeast 
genome data (Cherry et al., 2012). Whole-genome sequencing of the yeast S. cerevisiae 
genome is significant to this investigation. 
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Characteristics of the Fungal Kingdom 
The Kingdom Fungi is a highly diverse group of heterotrophic eukaryotes that can 
obtain nutrients either as saprophytes or as symbionts (e.g. with plant roots as a 
mycorrhiza). Members of the Kingdom Fungi can range from the unicellular budding 
yeasts (e.g. S. cerevisiae) and aquatic chytrids to larger mushrooms and even the colossal 
Armillarians. For example, a single individual of A. bulbosa, with an estimated biomass of 
10,000 kg, has been identified in a northern Michigan hardwood forest (Smith et al., 1992). 
This single clonal individual spans nearly 40 acres. Even larger Armillarians have been 
identified in the Pacific Northwest (Ferguson et al., 2003). In general, only about 100,000 
fungal species have been identified to date. However, conservative estimates suggest that 
the fungal kingdom likely contains between 2.2 and 3.8 million species (Hawksworth & 
Lücking, 2017). Thus, only about 3-8% of fungal species have been named so far. 
Unlike members of the other three eukaryotic kingdoms (Animalia, Plantae, and 
Protista), fungi characteristically contain cell walls that utilize chitin polymers. 
Additionally, chitin is the primary structural component in the exoskeleton of arthropods. 
Additionally, members of the Kingdom Plantae also contain cell walls. However, the major 
carbohydrate in plant cell walls is cellulose. Cellulose consists of linear chains of repeating 
β-1,4-linked D-glucose monomers. In contrast, glucose is replaced by N-acetylglucosamine 
monomers in chitin nanofibrils. Chitin plays an important role in the structure of fungal 
cell walls. In contrast to the more elastic β-glucan fibers, chitin confers the bulk of the 
wall’s rigidity and its ability to withstand both chemical and physical abuse (Fesel & 
Zuccaro, 2016). This resiliency stems in part from the insolubility of chitin in water. [Yeast 
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cell wall biology is of interest in this study and is discussed in more detail in a subsequent 
introductory sub-section.] 
Members of the Kingdom Fungi exhibit an alternation of generations between 
diploid, spore-producing sporophytes and haploid, gamete-producing gametophytes. As a 
member of the Kingdom Fungi, S. cerevisiae, too, exhibits this phenomenon. However, the 
gametophyte generation typically predominates. During both stages, the yeast S. cerevisiae 
grows via mitotic budding, a type of asexual reproduction. However, meiosis produces 
haploid spores from mature diploid sporophytes in response to stress during the early stages 
of sporulation (Neiman, 2011). Haploids are generally more efficient at reproducing and 
surviving. The metabolic trade-offs between these two ploidy stages suggest an adaptive 
function of meiosis and, thus, an underlying survival mechanism in response to stress 
conditions (Zörgö et al., 2013).  
Although the yeast S. cerevisiae can reproduce sexually, outcrossing is generally 
quite rare due to both mating types being produced in such close proximity within a single 
ascus (Ruderfer et al., 2006). Therefore, the rarity of outcrossing suggests that meiosis is 
conserved, not as a means of introducing genetic variation, but rather as a means of 
enhancing phenotypic stability and repairing DNA following periods of prolonged 
metabolic stress (Birdsell & Wills, 2003). This inherent stability of the fungal genome 






Diversity of the Ascomycete Fungi 
The ascomycetes represent the largest phyla of the Kingdom Fungi and consists of 
over 64,000 species (Hawksworth & Lücking, 2017). The unifying characteristic of 
Ascomycota is the presence of an ascus, a reproductive sac-like structure that contains the 
haploid ascospores (Neiman, 2005). The meiotic divisions during ascus formation do not 
culminate in cytokinesis. Instead, the meiotic nuclear products are individually captured 
and encased in new cell membrane and wall within the now anucleate ascus ‘sac.’ As a 
member of Ascomycota, S. cerevisiae too produce asci during sexual reproduction. 
However, the haploid stage predominates in domesticated yeast species.  
The phylum Ascomycota is subdivided into the three distinct subphyla 
Pezizomycotina, Saccharomycotina, and Taphrinomycotina (Eriksson & Winka, 1997). 
The subphyla Pezizomycotina is the largest subdivision of Ascomycota and contains over 
30,000 named species (Kirk et al., 2001). Pezizomycotinas are characterized by a 
predominately filamentous morphology and represent most of the fruiting ascomycetes. 
Pezizomycotinas can be found in both aquatic and terrestrial environments and as 
symbionts (e.g. mycorrhizae and lichens) and as pathogens (Spatafora et al., 2006; 
Sugiyama et al., 2006). Pezizomycotinas play significant roles in both human health and 
disease. For example, Penicillium rubens (or P. chrysogenum) is infamously known for its 
production of penicillin, one of the most widely used antibiotic agents, and Tolypocladium 
inflatum for its production of cyclosporin A, a potent immunosuppressant drug (Houbraken 
et al., 2011; Wenger, 1984). The World Health Organization considers both penicillin and 
cyclosporin A to be essential drugs within the context of even the most basic health-care 
systems. Finally, the pezizomycotina Neurospora crassa, named for the distinct axon-like 
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morphology of the spores, is a popular model organism in biochemistry, genetics, and 
molecular biology. The draft sequence of N. crassa was reported in 2003 and has since 
been thoroughly characterized and refined (Galagan et al., 2003). 
The subphylum Saccharomycotina consists of the classical ascomycete ‘yeasts’ 
including Candida albicans, Ashbya gossypii, and Saccharomyces cerevisiae (Eriksson & 
Winka, 1997). Although many members of this subphylum have tremendous commercial 
applications, some are indeed pathogenic and play significant roles in human health and 
disease. For instance, infection by C. albicans is the leading cause of mycosis-related death 
in the United States (Pfaller & Diekema, 2007). Although C. albicans is usually a 
commensal resident of the human gastrointestinal tract, immunocompromised and/or 
genetically predisposed individuals are especially susceptible to developing deadly 
candidiasis infections (Martins et al., 2014). A. gossypii has been the primary industrial 
commercial producer of riboflavin (vitamin B2) for many decades (Aguiar et al., 2015). 
Finally, the subphylum Taphrinomycotina consists of a diverse variety of taxa 
including Neolectomycetes, Pneumocystidomycetes, and Schizosaccharomycetes 
(Eriksson & Winka, 1997). The Neolecta species are characterized by fleshly yellowish-
orange unbranched (or branched) fruiting bodies (Landvik et al., 2003). A notable member 
of the Pneumocystidomycetes is Pneumocystis jirovecii, a commensal resident in the 
human lungs. Similar to candidiasis infections, P. jirovecii can cause deadly Pneumocystis 
pneumonia in immunocompromised individuals (Aliouat-Denis et al., 2008). Finally, 
although similar to S. cerevisiae, the Schizosaccharomycetes reproduce exclusively via 
medial fission, hence the nickname ‘fission yeast’ (Hoffman et al., 2015). 
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The Biology and Ecology of Saccharomyces cerevisiae 
The ability to maintain and propagate monoclonal strains of Saccharomyces 
cerevisiae have allowed scientists to study the genetics of what is effectively a few single 
individuals and, thus, rigorously characterize and document a few well-studied strains 
(Greig & Leu, 2009). Although select yeast strains are commonly employed in a variety of 
commercial processes such as baking/brewing and as a model organism in the laboratory, 
it remains unclear whether S. cerevisiae truly exists as a naturally occurring ‘wild’ species 
(Duina et al., 2014; Greig & Leu, 2009). Perhaps the distribution of S. cerevisiae in nature 
is, instead, largely artificial and simply the result of domestication. 
In these tightly controlled and unnatural domesticated contexts, yeasts have very 
little reason, if any, to adapt and, as such, very little is known about how S. cerevisiae 
responds to both intra- and interspecific competition within these “natural” microbial 
communities (Boynton & Greig, 2014; Jouhten et al., 2016). This significant knowledge 
gap severely handicaps the work towards a contextually accurate understanding of the 
relationship between the ecology, evolution, and genetics of S. cerevisiae. Therefore, the 
ecology of S. cerevisiae is vastly different from other ascomycetes in that this ecology is 
likely the result of domestication and, thus, is largely man-made. 
Genomic analyses have suggested that S. cerevisiae originated ‘out-of-China’ 
(Peter et al., 2018). This Chinese origin coincides with some of the earliest evidence of 
alcoholic drinks in recorded human history. Saccharomyces paradoxus, the closest known 
relative of S. cerevisiae, can be found as a commensal resident on the bark and leaves of 
deciduous trees throughout the northern hemisphere (Boynton & Greig, 2014; Greig & 
Leu, 2009). However, the bark and leaves of these deciduous trees are notably low-sugar 
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substrates. In contrast, S. cerevisiae most commonly grows on distinctly high-sugar 
substrates (e.g. the skin of grapes) and is well known for its efficiency in fermenting sugars 
to ethanol (Duina et al., 2014). Fortunately, S. paradoxus remains to be marred by the 
pressures of domestication and, thus, serves as a potential surrogate for studying and 
understanding the ecology, evolution, and genetics of these hypothetical ‘wild’ yeast 
populations (Dunham & Louis, 2011; Greig & Leu, 2009).  
In general, Saccharomyces species share similar biochemical phenotypes and 
morphologies (Boynton & Greig, 2014). Although S. cerevisiae and S. paradoxus are both 
mesophilic, the ideal temperature for S. paradoxus is slightly lower than that of S. 
cerevisiae. Furthermore, the biogeographical distribution of four distinct S. paradoxus 
strains throughout the northern hemisphere suggest that these yeasts can adapt to distinct 
climatic conditions and, thus, likely contain temperature-dependent genetic components 
(Leducq et al., 2014). 
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Biology of the Yeast Cell Wall 
The cell wall of the yeast Saccharomyces cerevisiae is a dynamic extracellular 
structural matrix that consists of several polysaccharide-based polymers including 
β-glucans (polymers of uridine diphosphate-N-glucose, UDP-Glc), chitin (a polymer of 
uridine diphosphate-N-acetylglucosamine, UDP-GlcNAc), and mannoproteins (proteins 
glycosylated with mannose) (Lesage & Bussey, 2006). The ability to regulate the 
biosynthesis and remodeling of the cell wall plays a critical role in maintaining cellular 
integrity during a variety of cellular events (i.e. division, growth, and mating) and in 
response to both environmental and metabolic stress conditions (Popolo et al., 2001). Thus, 
the biosynthesis and the remodeling of the cell wall are tightly controlled processes and 
critical to the survival of the yeast. 
In general, the cell wall in fungi and plants creates a strong, polysaccharide-protein-
based framework by which individual cells can act as structural bricks within some larger 
framework or body plan (Somerville et al., 2004). However, this role is irrelevant in 
unicellular fungi such as the yeast S. cerevisiae. In addition to these roles in maintaining 
cellular shape and protecting against stressful conditions, the cell wall is also involved in 
regulating the influx and efflux of water by osmosis by allowing cells to elastically expand 
or contract in response to changes in extracellular osmolarity (Klis et al., 2006). Although 
there is much inter-kingdom diversity in both cell wall composition and structure, the 
underlying secretory mechanisms and pathways involved in eukaryotic cell wall 
biosynthesis are, for the most part, highly conserved (Lesage & Bussey, 2006). In the yeast 
S. cerevisiae, the cell wall consists of approximately 85% polysaccharides and 15% 
proteins by mass (Nguyen et al., 1998). Furthermore, the cell wall can account for 
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approximately one-third of the dry mass of the yeast S. cerevisiae (Aguilar-Uscanga & 
Francois, 2003). 
The yeast cell wall primarily consists of an inner chitin/β-glucan matrix layer and 
an outer layer of mannoproteins. The space between the yeast cell wall and plasma 
membrane is traditionally referred to as the periplasmic space. Two distinct varieties of β-
glucans are found in yeast. These include β-1,3-glucans, which form the primary 
polysaccharide backbone, and shorter β-1,6-glucans, which form elongated, inter-
backbone branches (Lesage & Bussey, 2006). This branching network of 1,3 and 1,6 β-
glucans serves to both cross-link chitin polymers via β-1,4 glycosidic linkages and provide 
an overall spring-like resistance to the cell wall (Klis et al., 2006). Furthermore, the relative 
amounts of β-1,3 and β-1,6-glucans vary depending on the morphological state of the yeast 
(Magnelli et al., 2002). β-1,3-glucans are synthesized and translocated to the periplasmic 
space by β-1,3-glucan synthase, a transmembrane enzyme. This enzyme synthesizes β-1,3-
glucan from UDP-Glc, a cytoplasmic precursor, and extrudes newly synthesized linear β-
1,3-glucan strands into the periplasmic space where they are incorporated into the cell wall. 
β-1,3-glucan synthase consists of two catalytic subunits (encoded by FKS1 and GSC2) and 
one regulatory subunit (encoded by RHO1). Rho1 integrates a variety of signals from 
sensors in both the cell wall and the intracellular actin cytoskeleton (Lesage & Bussey, 
2006). However, much work remains in fully characterizing and understanding the central 
role of Rho1 in modulating β-1,3-glucan synthase activity. 
Chitin plays an important role in the maintenance of the yeast cell wall. In contrast 
to the more elastic β-glucan matrix, chitin confers the bulk of the walls rigidity and its 
ability to withstand both chemical and physical abuse (Fesel & Zuccaro, 2016). This 
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resiliency stems in part from the insolubility of chitin in water. Chitin is predominantly 
found close to the plasma membrane. Like β-1,3-glucan synthase, two transmembrane 
chitin synthases (Chs2 and Chs3) synthesize chitin by modifying and adding cytoplasmic 
UDP-GlcNAc precursors to the growing chain within the periplasmic space (Lesage & 
Bussey, 2006). These chitin synthases are activated at different times. Chs2 predominates 
during cytokinesis and Chs3 predominates during initial bud formation. 
The fungal cell surface and cell wall play critical roles in budding, mating, and cell 
fusion (Lussier et al., 1997). As such, the cell surface and cell wall vary immensely in 
composition, shape, and structure throughout the fungal life cycle.  
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Calcofluor White: An Inhibitor of the Cell Wall  
Calcofluor white (fluorescent brightener 28) is a fluorescent stain that associates 
strongly with chitin and cellulose (both structural polymers comprised of polysaccharides) 
and is commonly used in the detection of fungal, algal, and plant cell walls (Harrington & 
Raper, 1968; Herth & Schnepf, 1980; Nagata & Takebe, 1970). Calcofluor white has also 
been used to identify chitin in chitin-containing organisms such as arthropods and certain 
sponges (Ehrlich et al., 2013). 
The active fluorochrome is the disodium salt of a highly conjugated stilbene 
derivative (Harrington & Raper, 1968) (see Figure 3). Using ultraviolet and electron 
microscopy, Herth and Schnepf (1980) demonstrated that calcofluor white tightly 
associates via hydrogen bonding parallel to the longitudinal axis of chitin and cellulose. 
However, this strong association between calcofluor white and the longitudinal axis of 
chitin and cellulose can impair the nucleation and elongation of these polymers. 
 
 
 Figure 3. The molecular structure of calcofluor white. 
The active fluorochrome of calcofluor white fluoresces when it associates with β-
1,4 and β-1,3 glycosidic linkages found in cellulose and chitin, the primary 
structural component of plant and fungal cell walls, respectively. MW=960.95 
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Calcofluor white has been shown to negatively affect endogenous chitin 
polymerization and remodeling of the fungal cell wall. Roncero and Duran (1985) noted 
that a 2% calcofluor white solution dramatically inhibits the growth of wild-type S. 
cerevisiae. In addition to complete growth inhibition at high concentrations, Roncero and 
Duran (1985) observed varying responses in S. cerevisiae to differing calcofluor white 
concentrations. For instance, certain yeast strains were not appreciably affected by 
calcofluor white concentrations below 15 μg/ml. However, at intermediate concentrations 
with other strains, Roncero and Duran (1985) observed budding yeast failing to separate 
by producing distinctly abnormal multicellular aggregates and, thus, resulting in a dramatic 
decreased cell growth rate.  
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The Diversity of Peptidases and Proteolysis 
Proteases (peptidases) are enzymes that catalyze the post-translational (and usually 
irreversible) hydrolysis of peptide bonds covalently joining adjacent amino acids in 
substrate polypeptide chains. In general, these enzymes are classified according to the 
underlying mechanism of peptide bond hydrolysis. The MEROPS database represents the 
de facto standard in the field for classifying these diverse enzymes, their substrates and 
their inhibitors (Rawlings et al., 2018). For example, aspartic (A-), glutamic (G-), and 
metallo (M-) type peptidases typically employ a one-step catalysis; and cysteine (C-), 
serine (S-), and threonine (T-) peptidases typically employ a two-step catalysis. 
In one-step catalysis, an acidic amino acid (i.e. aspartate or glutamate) or a divalent 
cation (i.e. zinc) first polarizes a water molecule which then, in turn, directly catalyzes the 
hydrolysis of some targeted peptide bond via a classical nucleophilic attack and, thus, 
liberates two cleavage products. However, a two-step protease is first transiently bound to 
the targeted peptide covalently which, in turn, destabilizes the original peptide bond and 
displaces one cleavage product. However, the second cleavage product remains covalently 
linked to the protease until a water molecule can eventually perform a classical nucleophilic 
attack on this transient protease-substrate bond and, thus, liberate the second cleavage 
product. 
Carboxypeptidases are proteases that more specifically catalyze the hydrolysis of 
carboxy-terminal (c-terminal) amino acids from substrate polypeptide chains (Gomis-
Ruth, 2008). As a peptidase, carboxypeptidases too are classified according to the 
conventional MEROPS enzyme types (A-, C-, G-, M-, S-, T-, or U-) based on their 
structure and underlying catalytic mechanism (Rawlings et al., 2018). 
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The M14 Metallocarboxypeptidase Family 
Metallocarboxypeptidases (MCPs) or M-type carboxypeptidases are of interest in 
this study. Like other proteases, the catalytic activity of MCPs has been implicated in a 
variety of post-translational processing pathways, such as the processing of pro-hormones 
and neuropeptides (Arolas et al., 2007). One notable family of MCPs is the human M14 
family that contains 21 catalytically active members and four members predicted to be 
catalytically inactive (Pascual et al., 1989; Petrera et al., 2014; Reznik & Fricker, 2001; 
Tan et al., 1993) (see Figure 4).  
 
Figure 4. The human M14 metallocarboxypeptidase family. 
The human M14 family contains 21 catalytically active members and four members 
predicted to be catalytically inactive (*). The protein coded by ECM14 in 
Saccharomyces cerevisiae is homologous to human CPA1 (**).  
22 
Members of the human M14 family have been implicated in a variety of 
physiological functions and disease pathways. Three notable active members of the M14 
family are carboxypeptidase B2 (CBP2/TAFI/), carboxypeptidase E (CPE), and cytosolic 
carboxypeptidase 1 (CCP1/Nna1/AGTPBP1). These three members briefly illustrate the 
functional diversity of this enzyme family. 
1. Carboxypeptidase B2 (CBP2/TAFI/CPU) functions in blood plasma as an 
inhibitor in the fibrinolytic pathway (Eaton et al., 1991). Active plasmin alone 
is a very powerful hydrolyzer of fibrin, the fibrous structural protein involved 
in blood clot formation (Ezihe-Ejiofor & Hutchinson, 2013). CPB2 is 
synthesized by the liver as the zymogen proCPB2, a catalytically inactive 
precursor. Active CPB2 inhibits the fibrinolysis pathway by preferentially 
cleaving c-terminal lysine residues from fibrin, making fibrin less favorable for 
degradation by activated plasmin. Because the effect of active CPB2 is 
complemented with fibrin cross-linking and stabilization by coagulation factor 
XIII, a CPB2-deficiency alone does not lead to grossly impaired hemostasis 
(Nagashima et al., 2002). However, deficiencies in both CPB2 and coagulation 
factor XIII result in premature clot lysis and overall hemostasis dysregulation. 
2. Carboxypeptidase E (CPE/CPH) plays a ubiquitous role in the biosynthesis 
of nearly all neuropeptides and peptide hormones within the human body 
(Fricker, 2018). These peptides include insulin, vasopressin, oxytocin, and the 
enkephalins. Mice homozygous for the fat spontaneous mutation (Cpefat/Cpefat) 
exhibit a variety of endocrine disorders including hyperglycemia, infertility, 
insulin resistance, and obesity (Naggert et al., 1995). Although CPE mutations 
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within the human population are not common, a truncating mutation has been 
documented in a morbidly obese female with type II diabetes mellitus (Alsters 
et al., 2015). 
3. Cytosolic carboxypeptidase 1 (CCP1/Nna1/AGTPBP1) has been implicated 
in the deglutamylation (a post-translational modification) of tubulin during a 
variety of cellular events including axonal regeneration, axogenesis, 
dendritogenesis, and the synthesis and maintenance of the ciliary/flagellar 
axoneme (Kalinina et al., 2007; Otazo et al., 2013). Defective tubulin 
deglutamylation is responsible for neurodegeneration in the classical Purkinje 
cell degeneration (pcd) mouse, which lacks functional CCP1. These mice 
exhibit adult-onset degeneration of cerebellar Purkinje neurons, olfactory bulb 
mitral neurons, retinal photoreceptors, and select thalamic neurons. 
Catalytically active MCPs of the M14 family characteristically contain six 
conserved active site residues: H/His69 (histidine), E/Glu72 (glutamate) R/Arg127 
(arginine), R/Arg145, H/His196, and E/Glu270 (glutamate) (Auld, 2004; Lyons & Fricker, 
2011). [These numbers represent the positions of each residue in the mature polypeptide 
sequence of the prototypical carboxypeptidase, CPA1, from Bos taurus.]  
H69, E72, and H196 play roles in coordinating with a required zinc ion; R127 and 
R145 are involved in the binding of c-terminal carboxylate groups; and E270 functions as 
a catalytic general base (see Figure 5). Substitutions at any of these critical positions likely 
results in a loss of traditional carboxypeptidase-like activity. 
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Figure 5. The active site of the prototypical carboxypeptidase from Bos taurus. 
The active site of an metallocarboxypeptidase must contain two arginines (R127 
and R145) to bind the substrate c-terminus (shown in yellow), a glutamate (E270) 
to perform acid-base hydrolysis, and three other residues (H69, E72, and H196) for 
coordination with a zinc ion (gray sphere). The dipeptide glycyl-L-tyrosine 
substrate is shown in the active site (shown in yellow). Only the carboxypeptidase 




ECM14: A Fungal Pseudopeptidase 
The yeast Saccharomyces cerevisiae genome contains ≈6,000 genes (≈5,000 non-
essential and ≈1,000 essential) (Winzeler et al., 1999). [Non-essential genes are defined as 
being those that can be singularly disrupted without causing significant harm to an 
organism.] Of these genes, only one gene, ECM14, codes for a member of the M14 family 
of MCPs. The protein coded by ECM14 is homologous to human CPA1 (one of the 21 
catalytically active members of the M14 MCP family) (see above Figure 5). Although 
many amino acid residues are conserved between fungal Ecm14 and human CPA1, 
multiple   substitutions in the presumed active site of Ecm14 seem to indicate a loss of 
traditional carboxypeptidase-like activity (Idowu et al., 2016) (see Figure 6, Figure 7). 
 
Figure 6. Comparison of Ecm14 with bovine CPA1 indicates that Ecm14 is likely 
an inactive member of the M14 carboxypeptidase family. 
Ecm14 sequences from each of the three subphyla of Ascomycota are shown 
compared to B. taurus CPA1. The predicted cleavage sites for signal peptidase are 
shown in green. Possible sites at which a trypsin-like endopeptidase might cut to 
remove the prodomain are shown in pink. Critical active site amino acids are shown 




Figure 7. Ecm14 is similar to other metallocarboxypeptidases. 
The tertiary structure of Ecm14 was modeled using SWISS-MODEL and an X-ray 
crystal structure for human CPA1 (PDB ID 4UF4). The catalytic domain is shown 
in blue and the prodomain in green. Endopeptidase cleavage sites for trypsin are 
shown in pink and for chymotrypsin in yellow. Models were generated using 










At least within the context of routine laboratory growth conditions, ECM14 is a 
non-essential gene in the yeast S. cerevisiae genome (Winzeler et al., 1999). However, the 
conservation of ECM14 in the genome of ascomycete fungi, but not in other fungal phyla, 
suggests that Ecm14 does have some, albeit presently unknown, function (see Figure 8). 
 
 Figure 8. Ecm14 is conserved in Ascomycota, but not in other fungal phyla. 
CPA1-like fungal proteins fall into three broad categories based on active site 
residues: standard CPA/CPB proteins containing all expected active site residues, 
with representatives from all subphyla of fungi (blue box), basidiomycete CPA 
proteins containing expected active site residues with the exception of 5 closely 
aligned proteins from 5 different species containing R127Y, H196R, and E270H 
substitutions (green box), and Ecm14-like proteins found only in ascomycetes and 
defined by the presence of N144D and E270K substitutions. 
 
Prodomain cleavage is an essential feature of many catalytically active peptidases. 
For example, the model zinc protease, CPA1, is synthesized within the rough endoplasmic 
reticulum of pancreatic centroacinar cells as the zymogen proCPA1, a catalytically inactive 
precursor. This zymogen is secreted in response to stimulation of the pancreas by 
cholecystokinin (CCK), a digestive hormone. Once in the duodenum, proteolytic cleavage 
of the N-terminal prodomain (a 95-aa regulatory domain) liberates the catalytically active 
carboxypeptidase domain (see above Figure 7). Because cleavage of a prodomain is 
typically associated with activation in peptidases, retention of prodomain cleavage in 
Ecm14 likely suggests some underlying function to be regulated. 
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Previous work by Idowu et al. (2016) has demonstrated that both trypsin and 
chymotrypsin are able to cleave the prodomain of Ecm14 in vitro. Edman N-terminal 
degradation sequencing was performed by The Synthesis & Sequencing Facility at Johns 
Hopkins University (Baltimore, M.D.) in order to identify the location of these 
endopeptidase cleavage sites (see above Figure 7). Furthermore, previous work by Schott 
(2015) suggests that Ecm14 might be able to compete with active carboxypeptidases in 
vitro by binding and protecting c-terminal amino acid residues of potential substrates. 
Although this previous work has preliminarily suggested some activity of Ecm14 
in vitro, very little is known about the in vivo implications of the key amino acid 
substitutions in the presumed active site of Ecm14 (and pseudoenzymes in general). 
However, the present evidence suggests that Ecm14 is likely functional; not as a 
catalytically active enzyme, but rather as a binding protein that transiently interacts with 
other protein substrates and, thus, influences the intracellular localization and/or fate of 
these protein substrates. 
 The obscure functional nature of pseudoenzymes in general makes them inherently 
difficult to associate with a phenotype. Although previous studies have suggested several 
phenotypes for ECM14, the potential of these phenotypes for both reproducibility and 
quantification remains to be fully understood. However, a reproducible and readily 
quantifiable phenotype is fundamentally needed in order to systematically study the 
biochemical and biological implications of the key amino acid substitutions of 
pseudoenzymes in general. 
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Potential Phenotypes of ECM14 
In a genome-wide screen focused on characterizing yeast genes involved in cell 
wall architecture and remodeling, Lussier et al. (1997) identified Ecm14 as a possible 
player in this broad functional classification. Understanding the impact of calcofluor white 
on chitin polymerization and cell wall biosynthesis, Lussier et al. (1997) began by initially 
screening for any altered sensitivity to calcofluor white in transposon-mutagenized yeast 
cells. Ram et al. (1994) first postulated that exposure to calcofluor white amplifies the 
effect of mutations in genes specifically involved in cell wall architecture and remodeling. 
Additional supplemental screens were used to further characterize the impact of each 
mutated gene on a variety of phenotypes known to be related to cell wall biology. In 
addition to ECM14, at least 81 other genes in the yeast S. cerevisiae genome were 
identified, that when mutated, confer at least some modified sensitivity to calcofluor white 
(Lussier et al., 1997). An altered cell wall hexose composition (an increased mannose: 
glucose ratio) and a hypersensitivity to the antifungal compounds Hygromycin B and 
Papulacandin B were also observed in ecm14 mutants. 
In a genome-wide screen, Hillenmeyer et al. (2008) systematically subjected every 
non-essential gene knockout yeast strain to a variety of different chemicals and identified 
several potential fitness defects associated with ecm14 deletion. These fitness defects 
included a reduced sensitivity to paraquat, mercury chloride, and lithium chloride. 
However, Idowu et al. (2016) were unable to clearly replicate these results. It is theorized 
that a disturbed or weakened cell wall is simply not able to withstand drug or chemical 
concentrations as effectively as the more robust cell wall of wild-type yeast cells. 
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Therefore, a disturbed or weakened cell wall might also explain the fitness defects observed 
by Hillenmeyer et al. (2008) and Lussier et al. (1997). 
Finally, Schoner et al. (2008) identified arp1 ecm14 double mutants as potentially 
being inviable—a case of synthetic lethality. [Actin-related protein 1 (Arp1) serves as a 
filamentous core backbone in the dynactin complex, which functions in nuclear migration 
during mitosis (Igarashi et al., 2005). Additionally, Arp1 plays an essential role in ensuring 
the completion of cell wall remodeling prior to mitotic initiation.] However, like the fitness 
defects observed by Hillenmeyer et al. (2008) and Lussier et al. (1997), attempts to 
replicate these results have remained either incomplete or unsuccessful. [The concept of 




Intracellular Localization and Potential Biological Role of Ecm14 
In a cellular analysis of protein localization in S. cerevisiae, Huh et al. (2003) 
identified Ecm14 to be localized within the yeast vacuole, an important organelle involved 
in yeast cell wall architecture and remodeling. By inserting the coding sequence for green 
fluorescent protein (GFP) from Aequorea victoria (a bioluminescent jellyfish species) in-
frame immediately preceding the endogenous stop codon for each yeast ORF (open reading 
frame), Huh et al. (2003) were able to provide a comprehensive map of in vivo protein 
localization in the yeast S. cerevisiae. 
In yeast, the vacuole localizes the key enzymatic players of the macroautophagy 
pathway. [The yeast vacuole is functionally analogous to the lysosomes found in higher 
eukaryotes.] This ubiquitous homeostatic process facilitates the degradation of damaged 
organelles and misfolded proteins in response to a variety of metabolic signals and stressors 
(Levine et al., 2011). Furthermore, the vacuole is responsible for the degradation of several 
enzymes specifically implicated in cell wall biology (Wiederhold et al., 2009). For 
example, one recognized pathway for regulating chitin synthase II (Chs2) is via vacuolar 
degradation by the vacuolar aspartyl protease A (Pep4) (Chuang & Schekman, 1996). In 
response to some yet to be characterized signal, Chs2 is trafficked via endocytosis into the 
yeast vacuole by Sla2 for eventual degradation (Lesage & Bussey, 2006). 
Like Ecm14, Proteinase C (Prc1, a serine carboxypeptidase Y) and Autophagy-42 
(Atg42, a functional homologue of Prc1) are both localized in the yeast vacuole (Huh et 
al., 2003). Parzych et al. (2018) demonstrated that deficiencies in both Atg42 and Prc1 
result in several defects in the yeast macroautophagy pathway. Following hydrolysis, the 
resultant components are released into the cytosol via newly synthesized permease-like 
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proteins (Yang et al., 2006). However, the present evidence suggests that yeast with 
mutations in both Atg42 and Prc1 have significant deficiencies in the breakdown of 
autophagic-bodies, the activation of vacuolar zymogens, and the synthesis of various 
autophagy-dependent proteins (Parzych et al., 2018). 
Another vacuolar carboxypeptidase in S. cerevisiae is Carboxypeptidase S (Cps1). 
Bordallo and Suarez-Rendueles (1993) demonstrated that yeast pre-cultured in a nitrogen 
and glucose-rich growth medium show a dramatic increase in CPS1 expression when 
subsequently deprived of nitrogen. Like Atg42 and Prc1, the upregulation of Cps1 activity 
during periods of nutrient deprivation likely suggests a crucial mechanism of homeostasis. 
In the case of Cps1, this mechanism seems to invoke the recycling of certain peptides (as 
catalyzed by Cps1) for use as an alternative source of metabolic nitrogen during periods of 
nitrogen depravation (Bordallo & Suarez-Rendueles, 1993). 
Although Ecm14 seems to lack traditional carboxypeptidase-like activity, its 
homology with active peptidases, its implication in resistance to calcofluor white, and its 
localization in the yeast vacuole seem to suggest a possible uncharacterized role in cell 
wall architecture and remodeling. 
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Synthetic Lethality and the Synthetic Lethal Screen 
The phenomenon of synthetic lethality occurs when two or more genetic 
perturbations together result in cellular death (Dobzhansky, 1946; Nijman, 2011). 
Biochemical pathways typically involve multiple key genetic components and it is thought 
that many of these key gene players can provide some redundancy in the event that other 
genes experience deleterious mutations (see Figure 9). Although enzymes are generally 
characterized based on a primary native reaction, enzymes (and potentially their inactive 
homologues) can also participate in numerous secondary side reactions and processes. This 
theory of “genetic robustness” suggests that organisms are quite resistant to major 
phenotypic changes despite inherent genetic variability, environmental changes and 
random mutation events. 
 
Figure 9. The phenomenon of synthetic lethality. 
Biochemical pathways typically involve multiple key gene components and many 
of these key gene players provide redundancy if other genes experience deleterious 
mutations (*). The synthetic lethal screen identifies novel mutants (gene-y) whose 




One method for exploring the function of non-essential genes is the synthetic lethal 
screen. This screen incorporates a convenient color-colony reporting assay to quickly 
visualize dependence on a plasmid carrying a gene of interest required for cell survival 
(Barbour et al., 2000; Koshland et al., 1985). The color-colony reporting assay exploits the 
de novo adenine biosynthesis pathway involving at least seven major genetic players 
(named ADE1-7). In short, cells carrying an ade2 mutation accumulate the intermediate 
P-ribosylaminoimidazole, which is oxidized to a red pigment. However, the ade3 mutation 
is epistatic to ade2 and, thus, blocks the pathway at a point prior to pigment formation. 
Thus, both wild-type and ade3/ade2 double mutant yeasts are white, and ade2 single 
mutant yeast are red (see Figure 10). However, double ade3/ade2 mutant yeasts 
transformed with a plasmid carrying a functional ADE3 gene are red (see Figure 10). 
Transformants that only weakly retain the plasmid will produce red and white sectored 
colonies to varying degrees. 
 
Figure 10. The genetic basis for the red-white color-colony assay in yeast. 
(1) Wild-type yeast are white. (2) Yeast that contain a single ade2 mutation 
accumulate a red pigment (oxidized P-ribosylaminoimidazole). (3) Yeast that 
contain both ade3 and ade2 mutations result in white colonies. (4) These double 
mutants that are transformed with a plasmid containing a functional ADE3 gene 
[pADE3] are red. 
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A synthetic lethal screen begins by first deleting a gene of interest in a yeast strain 
that is already deficient in the adenine biosynthesis pathway (ade3/ade2 mutants that 
produce white colonies). [The yeast gene deletion strategy is discussed in more detail in a 
subsequent methods sub-section.] Additionally, this host yeast strain must also contain an 
auxotrophic marker for selecting transformants (e.g. ura3Δ is commonly used) and 
complementary auxotrophic or drug resistance markers for selecting diploids from mating 
reactions (Sadowski et al., 2008). In URA3-based selection, the plasmid DNA has a wild-
type copy of the yeast URA3 gene, as well as the URA3 promoter; however, the host yeast 
strain lacks the URA3 allele. Thus, yeast cells transformed with the plasmid have a 
functional copy of the URA3 gene, which allows them to grow on media lacking uracil. 
Conversely, URA3-based selection also enables negative selection against plasmids 
containing URA3 when grown on media containing 5-fluoroorotic acid (5-FOA). When 5-
FOA is added to the growth media, the active URA3 gene product (orotidine 5'-phosphate 
decarboxylase) converts 5-FOA into the toxic compound 5-fluorouracil (5-FU). These 
URA3-containing plasmids are effectively destabilized and rapidly lost when grown on 
media containing 5-FOA. The S. Cerevisiae W303 strain (MATa/MATα {leu2-3,112 
trp1-1 can1-100 ura3-1 ade2-1 his3-11,15}) is commonly used as the parent strain when 
performing synthetic lethal assays (Cherry et al., 2012). 
After creating a suitable knockout W303-derived yeast strain, a wild-type copy of 
the gene of interest is cloned into a plasmid specifically designed for yeast synthetic lethal 
screens (Barbour et al., 2000). As a shuttle vector, this pSLS1 plasmid contains sequences 
for proliferation and selection in both bacteria and yeast. As a vector for synthetic lethal 
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screens, this pSLS1 plasmid also contains a functional ADE3 gene and a yeast centromere 
(CEN4) under the influence of a galactose promotor (pGAL1) (see Table 2 and Figure 11).  
 
Figure 11. The pSLS1 plasmid for yeast synthetic lethal screens. 
The pSLS1 plasmid contains the bacterial origin of replication sequence (ORI), the 
ampicillin resistance gene (AmpR) for selection in bacteria, the CEN/ARS 
sequence for replication in yeast, the URA3 gene for selection in yeast, and the 





When grown on media containing galactose, the galactose promotor erroneously 
induces transcription through the traditionally un-transcribed CEN4 sequence (see above 
Figure 11). The CEN4 sequence normally causes these yeast centromere plasmids (YCp) 
to behave like low-copy, “mini-chromosomes” during cell division (Clarke & Carbon, 
1980). However, erroneous transcription through the centromere sequence causes these 
YCp plasmids to instead behave like highly unstable yeast replicating plasmids (YRp). 
Therefore, providing galactose as a carbon source functions as a molecular switch causing 
the pSLS1 centromere plasmid to instead behave more like a replicating plasmid (Barbour 
et al., 2000). This ability to regulate plasmid stability in vivo is an essential requirement for 
effective synthetic lethal screens and has been shown to significantly reduce the number of 
false positives that must be subsequently screened and interrogated (Barbour et al., 2000). 
The synthetic lethal screen functions on the basis that dependence of the gene of 
interest for survival will cause yeast to retain the plasmid and, thus, produce non-sectored 
red colonies when grown on galactose-containing media (Barbour et al., 2000). However, 
yeast that are not dependent on the plasmid for survival will rapidly lose the plasmid when 
grown on galactose-containing media and produce red and white sectored colonies, or even 
solid white colonies, depending on the rate of plasmid retention. It is thought these sectored 
colonies are caused by the natural differential retention of the plasmid under various non-
essential contexts and should ideally be avoided when selecting candidate yeast colonies 
for further investigation. 
Spontaneous mutations occur at a rate far too low to be practically useful for most 
genetic screens. However, carefully prescribed treatment with either ethyl methansulfonate 
(EMS) or ultraviolet (UV) light can significantly increase the rate of mutations per gene 
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without the excessive killing of cells (Winston, 2008). As a potent base-altering agent, 
EMS is known to add an ethyl group to guanine, forming O6-ethylguanine (see Figure 12). 
This alkylated guanine can no longer form the typical three hydrogen bonds with cytosine 
and, thus, can erroneously be mispaired with thymine by DNA polymerase during DNA 
replication, causing G/C→A/T transitions (Brookes & Lawley, 1961). Since stop codons 
are rich in ATs (i.e. TAA, TGA, and TAG), EMS-based mutagenesis is effective for 
generating nonsense mutations. Because truncated gene products are generally not useful 
or even partially functional, these types of nonsense mutations are preferred when 
conducting synthetic lethal screens. 
 
 Figure 12. EMS-induced alkylation of guanine to form O6-ethylguanine. 
Guanine can form three hydrogen bonds (*). However, O6-ethylguanine can only 
form two hydrogen bonds (*) and, thus, can erroneously mispair with thymine 
during DNA replication. 
  
 The synthetic lethal screen can be described by three primary steps. First, a W303-
derived knockout yeast strain is transformed with a pSLS1-based plasmid containing a 
wild-type copy of the gene of interest (GENE-X). Next, random mutagenesis introduces 
random point mutations throughout the yeast genome. Finally, these mutagenized yeasts 
are cultured and screened on galactose-rich media to induce plasmid destabilization and 




Figure 13. The synthetic lethal assay is used to identify novel mutant yeast strains 
whose survival is dependent on a gene of interest. 
(1) A wild-type gene of interest (GENE-X) is first moved from the yeast genome 
into the pSLS1 vector (pSLS1-GENE-X). (2) Random genomic point mutations are 
introduced throughout the yeast genome using ethyl methansulfonate (EMS) or 
ultraviolet (UV) light. (3) Colonies that depend on the gene of interest for survival 




GENERAL MATERIALS AND METHODS 
Yeast Cell Culture and Media 
YEPD media (Yeast Extract 10 g/l, Peptone 20 g/l, Dextrose 20 g/l) was used for 
the routine maintenance and propagation of yeast. When necessary, this routine YEPD 
growth media was also supplemented with 8 ml/l of 0.5% (w/v) adenine (YEPD+Ade) for 
yeast strains deficient in adenine biosynthesis. Filter-sterilized Geneticin® (G418 sulfate, 
500 μg/ml) was used to select for yeast containing the KanMX allele. Filter-sterilized 
nourseothricin sulfate (NTC, 100 μg/ml) was used to select for yeast containing the NatMX 
allele. Both G418 and NTC were added to warm media (≈55°C). When preparing Petri 
dishes, agar was added at 20 g/l. 
SC-Ura media (Synthetic Complete minus Uracil) was used to positively select for 
yeast transformed with a plasmid containing the URA3 allele. This SC-Ura media 
contained 1% (w/v) succinic acid, 0.6% (w/v) sodium hydroxide, 0.67% (w/v) yeast 
nitrogenous base, and 1% (w/v) casamino acids. A 0.5% (w/v) autoclaved adenine stock 
was added at 8 ml/l. A 1% (w/v) filter-sterilized tryptophan stock was added at 2 ml/l (small 
drips of 3 M sodium hydroxide were added, as necessary, to increase tryptophan solubility 
in water). A 20% (w/v) dextrose stock was autoclaved separately in order to prevent 
caramelization and undesirable Maillard side reactions with amino acids in solution. This 
20% (w/v) dextrose stock was added at 100 ml/l. Adenine, tryptophan and dextrose were 
added to warm media (≈55°C). When preparing Petri dishes, agar was added at 20 g/l. 
SC+5FOA media (Synthetic Complete plus 5-Fluoroorotic Acid) was used to 
negatively select for yeast transformed with a plasmid containing the URA3 allele. This 
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SC+5FOA media was made as above, with the addition of a 0.2% (w/v) autoclaved uracil 
stock that was added at 5 ml/l. Finally, 100X 5-FOA from Zymo Research (100 mg/ml in 
DMSO) was added to warm media at 10 ml/l. 
YPGal media (Yeast Extract 10 g/l, Peptone 20 g/l, Galactose 20 g/l) was used for 
the destabilization of yeast centromere plasmids (YCp) under the influence of the galactose 
promoter (GAL1). A 20% (w/v) galactose stock was either autoclaved separately or filter-
sterilized in order to prevent caramelization and undesirable Maillard side reactions with 
amino acids in solution. Galactose was added to warm media (≈55°C). When preparing 
Petri dishes, agar was added at 20 g/l. 
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Bacterial Cell Culture and Media 
Luria broth (sodium chloride 10 g/l, tryptone 10 g/l, and yeast extract 5 g/l) was 
used for the routine maintenance and propagation of DH5α Escherichia coli. Filter-
sterilized 1000X ampicillin stock (100 mg/ml) was added to warm media (≈55°C) at 1 ml/l 
(or μl/ml). When preparing plates, agar was added at 15 g/l. For blue-white screening 
plates, filter-sterilized 100X IPTG (100 mM) and filter-sterilized 100X X-Gal (20 mg/ml) 
were added to warm media (≈55°C) at 10 ml/l (or μl/ml).  
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Gel Extraction and Cleanup of Large DNA Fragments 
The Qiagen QIAquick™ Gel Extraction Kit was used to cleanup DNA fragments 
from agarose gels following various enzymatic reactions. Although the QIAquick Gel 
Extraction Kit is only officially rated for up to 10 μg DNA (70-bp to 10-kb), several 
modifications to the included quick-start protocol allowed for the dependable extraction of 
larger DNA fragments (>10-kb). Bands of interest were sparingly visualized using UV 
transillumination, excised using clean scalpel blades (either fresh or cleaned using RNase 
AWAY™ as a DNA decontamination reagent), and transferred into tared 2-ml 
microcentrifuge tubes. Gel slices were excised and trimmed to <400 mg per extraction 
tube. Gel slices were incubated at 50°C for 10 minutes in three gel volumes of Buffer QG. 
Each incubating gel slice was vortexed every 2 minutes in order to thoroughly dissolve 
each gel slice. One gel volume of isopropanol was added to each tube and thoroughly 
vortexed. Each sample was applied to the center of a fresh QIAquick spin column, 
centrifuged for 90 seconds at 21,130g, and the flow-through discarded (this was repeated 
as needed for sample volumes >750 μl). An additional 500 μl of fresh Buffer QG was 
washed through each column in order to remove all traces of agarose. 750 μl of Buffer PE 
was carefully added to the center of each spin column and allowed to incubate at room 
temperature for >5 minutes. The Buffer PE wash was centrifuged for 90 seconds at 21,130g 
and the flow-through discarded. Each spin column was subsequently rotated 180 degrees 
and centrifuged for an additional 90 seconds at 21,130g to remove any residual Buffer PE. 
Residual Buffer PE (containing ethanol) can interfere with downstream applications. DNA 
was eluted by carefully applying 50 μl of warm Buffer EB (55-65°C) to the center of each 
spin column and allowing each to incubate at room temperature for >5 minutes. Each spin 
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column was placed into a clean 1.5-ml microcentrifuge tube and centrifuged for 90 seconds 
at 21,130g to elute the DNA. Multiple spin columns were used for samples exceeding 400 
mg. Serial elutions were used to successively collect and concentrate DNA from multiple 
columns. Final preparations were stored at -20°C. 
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Isolation of Yeast Genomic DNA for PCR-based Applications 
Yeast genomic DNA (gDNA) was isolated using an inexpensive and quick 
approach based on a technique by Looke et al. (2011) from the Institute of Molecular and 
Cell Biology, University of Tartu, Estonia. Either a single colony or 200 μl of mid-log 
phase liquid culture (1-5x107 cells/ml, OD600 = 0.4-1.7) was resuspended in 100 μl of fresh 
200 mM lithium acetate, 1% SDS solution and incubated for 10 minutes at 70°C. 300 μl of 
100% ethanol was added and samples were thoroughly vortexed prior to 3 minutes of 
centrifugation at 21,130g. Samples were carefully decanted and the supernatant discarded. 
Pellets were subsequently re-washed with 500 μl of 70% ethanol and allowed to air-dry for 
>10 minutes prior to being resuspended in 100 μl of Qiagen® Buffer EB (10 mM Tris-Cl, 
pH 8.5). Samples were briefly centrifuged for 15 seconds to collect cell debris and 1 μl of 
supernatant was used for PCR template DNA. 
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Isolation of Plasmid DNA From Bacterial Cells Using the NID Method 
Plasmid DNA was routinely isolated using the “one-step, one-tube” non-ionic 
detergent (NID) method demonstrated by Lezin et al. (2011). The NID extraction buffer 
(5% sucrose, 20-50 mM EDTA, 50 mM Tris pH 8, 0.75 M NH4Cl, and 0.5% Triton X-100) 
was stored without enzyme at 4°C. A separate 100X enzyme stock (10 mg/ml lysozyme, 
2.5 mg/ml RNase A, 50 mM Tris pH 8, and 50% glycerol) was stored at -20°C and added 
as necessary. For small 50-μl minipreps, LB/Amp cultures (2-4 ml) were inoculated with 
fresh monoclonal bacterial colonies-of-interest and cultured overnight for 16-18 hours at 
37°C with shaking at 250 RPM. These overnight cultures were split into 2-ml 
microcentrifuge tubes and pelleted at 5,000g for 1 minute. Each decanted pellet was 
thoroughly resuspended in 150 μl of extraction buffer (with enzymes) and incubated at 
65°C for 5-7 minutes. For overnight cultures >2 ml, identical pellets were serially 
resuspended and collected in the same 150 μl of extraction buffer (with enzymes) prior to 
incubation for increased plasmid concentrations. Suspensions were centrifuged at 21,130g 
for 10 minutes and each cellular pellet was carefully removed using a sterile toothpick. 
Plasmid DNA was precipitated and pelleted by adding 120 μl of isopropanol, followed by 
thorough mixing and centrifugation at 5,000g for 10 minutes. Finally, 500 μl of 70% 
ethanol was added, followed by centrifugation at 21,130g for 10 minutes. After removing 
the ethanol supernatant, each pellet was allowed to thoroughly dry for 10-15 minutes prior 
to being dissolved in 50 μl of Qiagen Buffer EB. 
Large 200-μl maxipreps were prepared by first inoculating 1-ml LB/Amp seed 
cultures with fresh monoclonal bacterial colonies-of-interest and incubating for 8 hours at 
37°C with shaking at 250 RPM. These 8-hr seed cultures were then used to inoculate larger 
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100-ml LB/Amp cultures that were subsequently incubated overnight at 37°C with shaking 
at 250 RPM. Each 100-ml overnight culture was divided between three sterile 50-ml 
centrifuge tubes and pelleted at 5,000g for 5 minutes in a refrigerated centrifuge (4°C). 
Identical pellets were serially resuspended using 10 ml of prepared NID extraction buffer 
and consolidated into one 50-ml centrifuge tube. Suspensions were incubated in a water 
bath at 65°C for 8 minutes and centrifuged at 13,000g for 30 minutes in a refrigerated 
centrifuge (4°C). Plasmid DNA was precipitated and pelleted by adding 1 ml of 
isopropanol, followed by thorough mixing and centrifugation at 13,000g for 15 minutes in 
a refrigerated centrifuge (4°C). Each plasmid pellet was thoroughly resuspended in 1.5 ml 
of 70% ethanol, transferred to a clean 1.5-ml microcentrifuge tube, and centrifuged at 
21,130g for 5 minutes at room temperature. After removing the ethanol supernatant, each 
pellet was allowed to thoroughly dry for 10-15 minutes prior to being dissolved in 500 μl 
of Qiagen Buffer EB. 
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DNA Quantification using ImageJ 
DNA agarose gels were imaged using the AlphaImager HP™ gel imaging system 
and analyzed using NIH ImageJ (Rueden et al., 2017). These images were intentionally 
captured using a very low auto exposure profile to ensure more accurate final band 
quantification. Each gel image was opened in ImageJ and a bounding box was drawn 
around the entire DNA ladder using the Rectangle Tool. This first lane was marked by 
either pressing Control + 1 or via the Analyze > Gels > “Select First Lane” menu option. 
The box was then duplicated onto each lane of interest by dragging and marking these 
subsequent lanes by either pressing Control + 2 or via the Analyze > Gels > “Select Next 
Lane” menu option. The “Invert peaks” option was unselected (Analyze > Gels > “Gel 
Analyzer Options…”). Finally, lanes were plotted by either pressing Control + 3 or via the 
Analyze > Gels > “Plot Lanes” menu option (see Figure 14). 
Each peak of interest was area-bound by drawing a line using the straight-line tool 
underneath each peak between the predominate points of inflections above baseline. The 
magic wand tool was then used to select each enclosed, area-bound peak and each peak 
was labeled using the Analyze > Gels > “Label Peaks” menu option. Usually the bright 
3.0-kb TriDye band was used as a reference standard for all DNA quantification 
experiments. When using a 5 μl load of TriDye, the 3.0-kb band has as reference mass 
(Rmass) of 62.5 ng. The masses of each band of interest (Bmass) were calculated by simply 
relating the known peak area (Rarea) and mass (Rmass) of the 3.0-kb TriDye band to the peak 






The mass of each band of interest was then converted to concentration (ng/μl) by 
dividing by the volume of DNA that was loaded into the agarose gel. This volume of DNA 
was usually the amount used in a preceding diagnostic restriction digest (e.g. 5 μl). 
 
Figure 14. DNA quantification using ImageJ and Microsoft Excel. 
(A) The DNA ladder lane and any additional lane-of-interest is selected in ImageJ 
using the rectangle tool. (B) The peak intensities of each lane are then automatically 
plotted, and each peak is area-bound using the straight-line tool. (C) Each area-
bound peak is then selected using the magic-wand tool and labeled. (D) Finally. 







PLASMID CONSTRUCTION METHODS AND RESULTS 
High-Fidelity PCR Amplification of Wild-type ECM14 
Primer sequences for amplifying the Saccharomyces cerevisiae ECM14 
(YHR132C) open reading frame (ORF) were obtained from the Saccharomyces Genome 
Deletion Project (Baudin et al., 1993; Wach et al., 1994). These forward (_A) and reverse 
(_D) ORF primers are designed to also include several hundred bases of flanking sequence 
around the targeted gene to ensure adequate coverage of both endogenous promotor and 
terminator sequences. As such, amplicons produced using these forward and reverse 
primers (e.g. ECM14_A and ECM14_D) are referred to as “expression cassettes.” In 
addition to the standard ECM14_A and ECM14_D primers, slightly modified primers were 
designed to include a 5’ BamHI restriction site (ECM14_A-BamHI and ECM14_D-
BamHI) for future ligation into various plasmid vectors. These BamHI primers also 
included a 4-bp TATA sitting sequence preceding the GGATCC BamHI recognition site 
on the 5’ end to facilitate optimal enzyme binding and interaction. All primers were ordered 
from Thermo Fisher Scientific® (see Table 1) and reconstituted with Buffer EB (10 mM 
Tris-Cl, pH 8.5) to 100 μM. These reconstituted primers were further diluted to a final 
working concentration of 10 μM before being used in PCR or Sanger sequencing reactions.  
Genomic DNA was extracted from ECM14 wild-type Y1239 yeast cells cultured 
on standard YEPD media. The high-fidelity Platinum SuperFi® DNA Polymerase from 
Invitrogen® was used to amplify the ECM14 ORF. A PCR master mix was prepared for 
n+1 reactions (n=4) by combining 127.5 μl of sterile Milli-Q® water, 50 μl of 5X SuperFi 
buffer, 20 μl of 2mM dNTP mix, and 2.5 μl of SuperFi DNA Polymerase (2 U/μl). Either 
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5 μl or 1 μl of Y1239 gDNA was used as template DNA with both the standard ECM14 
and modified ECM14-BamHI primers to a final volume of 50 μl per reaction. Forward and 
reverse primers were added to a final concentration of 0.5 μM. Each reaction tube was 
capped and carefully mixed before placing into a Bio-Rad® T100 Thermal Cycler. The 
following thermal profile was performed: initial denaturation at 98°C for 30 seconds, 
followed by 35 cycles of denaturation at 98°C for 10 seconds, annealing at 63.6°C for 10 
seconds, and extension at 72°C for 60 seconds. The profile was completed with a final 
extension at 72°C for 5 minutes. Each PCR reaction was combined with 10 μl of New 
England Biolabs’® Gel Loading Dye, Purple (6X) and ran in a 0.8% agarose gel (0.5 μg/ml 
EtBr) for visualization and gel extraction/cleanup (see Figure 15). 
The pSLS1 vector contains only three unique restriction sites (BamHI, SalI, and 
SmaI) for subcloning applications (see above Figure 11). Thus, it was required to utilize 
custom PCR primers in order to introduce novel restriction sites (preferably those with 
sticky ends) flanking the traditional ECM14 amplicon. The original ECM14_A and 
ECM14_D primers from the Saccharomyces Genome Deletion Project were used as a 
control to demonstrate amplification of wild-type ECM14 (1.9 kb) from Y1239 gDNA.  
 
Figure 15. High-fidelity PCR amplification of wild-type ECM14. 
The original ECM14_A and ECM14_D primers were used to demonstrate 
amplification of wild-type ECM14 (1.9 kb) from Y1239 gDNA. Custom 
ECM14_A and ECM14_D primers were designed to harbor terminal BamH1 
restriction sites to facilitate future ligation into various plasmid vectors. Either 1 μl 
or 5 μl of template Y1239 gDNA was used in each PCR reaction. All four reactions 
were successful in amplifying ECM14. 
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Cloning of Wild-type ECM14 into pBluescript 
 The ECM14 PCR product harboring terminal BamHI restriction sites and the target 
pBluescript II SK(+) plasmid vector were both digested with the New England Biolabs’ 
BamHI-HF restriction enzyme. [Although there are four commercially available variants 
of the pBluescript II vector, these differences were not of interest in this study. Any one of 
these pBluescript variants can be used as a routine cloning plasmid.] For the ECM14-
BamHI PCR product, 50 μl of gel-purified PCR product was combined with 6 μl of 
CutSmart Buffer, 2 μl of sterile Milli-Q water, and 2 μl of BamHI-HF enzyme. For 
pBluescript II SK(+), 2 μl of pBluescript plasmid (1 μg/μl) was combined with 15 μl of 
sterile Milli-Q water, 2 μl of CutSmart Buffer, and 1 μl of BamHI-HF enzyme. Both 
digestion reactions were thoroughly incubated at 37°C for >1 hour and were cleaned up 
immediately using the QIAquick gel extraction kit without actually running each digest in 
an agarose gel (3 volumes of Buffer QG and 1 volume of isopropanol were simply added 
prior to applying each digest to a fresh spin column). The pBluescript-BamHI digest was 
additionally treated with 1 μl of New England Biolabs’ Calf Intestinal Alkaline 
Phosphatase (CIAP) to remove 5’ terminal phosphate groups and, thus, prevent vector re-
circularization during subsequent ligation reactions. This CIAP-treated pBluescript-BamHI 
digest was also cleaned up immediately using the QIAquick kit. Each cleaned-up digest 
was quantified in a 0.8% agarose gel (0.5 μg/ml EtBr) with 5 μl TriDye Ladder as a 
reference standard. 
The ECM14-BamHI insert was ligated into the pBluescript-BamHI-CIAP vector 
using T4 DNA ligase with a standard vector-to-insert ratio of 1:3. The ligation reaction 
contained 6 μl of pBluescript-BamHI-CIAP (0.042 pmol), 4 μl of ECM14-BamHI (0.126 
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pmol), 7 μl of sterile Milli-Q water, 2 μl of T4 DNA ligase buffer, and 1 μl of T4 DNA 
ligase. The ligation reaction was incubated at 24°C for 1 hour. Three 50-μl aliquots of 
Invitrogen Subcloning Efficiency™ DH5α Competent Cells were slowly thawed on wet 
ice and mixed with either 5 μl of sterile Milli-Q water (negative control), 5 μl pBluescript-
ECM14 ligation mixture, or 1 μl pBluescript (positive control). Each transformation 
mixture was incubated on wet ice for 30 minutes, heat shocked at 42°C for 45 seconds, and 
returned to wet ice for 5 minutes. Each reaction was incubated for 60 minutes at 37°C in 
200 μl of fresh LB without ampicillin to allow for adequate expression of the ampicillin 
resistance gene prior to plating. These outgrowth cultures were subsequently plated on dry 
IPTG/X-Gal LB agar plates with ampicillin (starting with the negative control first), 
incubated at 37°C overnight for >20 hours, and screened for white colonies. 
Four putative pBluescript-ECM14 colonies (white) were cultured overnight, 
miniprepped using the NID method, and digested with BamHI-HF enzyme at 37°C for 60 
minutes. Each of these diagnostic restriction digests included 5 μl of plasmid DNA, 12 μl 
of sterile Milli-Q water, 2 μl of CutSmart Buffer, and 1 μl of BamHI-HF enzyme. Each 
digest was electrophoresed in a 0.8% agarose gel (0.5 μg/ml EtBr) at 100V until sufficient 
band separation (see Figure 16). The combined peak area of both the pBluescript band and 




Figure 16. Cloning of Wild-type ECM14 into pBluescript. 
The wild-type ECM14 PCR product harboring terminal BamHI sites and the 
pBluescript II SK(+) vector were first digested with BamH1. The pBluescript 
vector was then treated with an alkaline phosphatase (CIAP) prior to ligation by T4 
DNA ligase. Four putative pBluescript-ECM14 preparations and empty pBluescript 
II (3.0 kb) were digested with BamHI to confirm the presence or absence of the 




Confirmation of ECM14 Sequence Accuracy 
 Sanger sequencing was performed by GenScript (Piscataway, N.J.) The four 
putative pBluescript-ECM14 plasmids were sequenced using the ECM14_A, ECM14_D, 
and ECM14_Internal primers (see Table 1) to ensure adequate sequencing coverage of the 
ECM14 gene insert. Three sequencing samples for each plasmid were prepared by 
premixing 10 μl of plasmid DNA (>50 ng/μl), 2.5 μl (50 pmol) of primer (either 
ECM14_A, ECM14_D, or ECM14_Internal), and 2.5 μl of sterile Milli-Q water. Samples 
were shipped overnight in 1.5-ml microcentrifuge tubes sealed with Parafilm. 
 Sequencing results were first processed by visually inspecting the chromatograms 
using either Chromas or UGENE for base call quality and subsequently truncating any poor 
terminal sequence as necessary (Okonechnikov et al., 2012). Each sequence was then 
aligned with the wild-type ECM14 reference sequence using NCBI Nucleotide BLAST 
(BLASTn) and inspected for any sequence gaps and erroneous base identities. Any 
discrepancies were further considered by manually re-inspecting the chromatograms and, 
when possible, comparing regions of overlapping sequence coverage for any additional 
clues for determining consensus. Finally, the three contiguous sequences were assembled 
using the CAP3 sequence assembly program and saved in FASTA format. 
The ECM14 insert sequence produced by this study was merged with the 
pBluescript II SK(+) sequence in SnapGene to produce new recombinant pBluescript-





Figure 17. Diagrams of the ECM14-BamHI PCR product, the pBluescript II SK(+) 
vector, and both orientations of the pBluescript-ECM14 recombinant plasmid. 
(A) The ECM14 PCR product harboring terminal BamHI restriction sites. Relevant 
primer sites for amplification and sequencing are annotated. (B) The pBluescript II 
SK(+) plasmid contains a multiple cloning site (MCS) and blue-white screening 
capability (LacZα). (C, D) Either ECM14 insert orientation is possible in the 
recombinant pBluescript-ECM14 plasmid due to only one restriction enzyme being 
used for cloning. Only plasmid features relevant to this study are annotated (*). 
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Subcloning of ECM14 from pBluescript-ECM14 into pSLS1 
 The wild-type ECM14 gene insert was subcloned from the pBluescript-ECM14 
(4,838-bp) parent plasmid into the pSLS1 (10.8-kb) destination plasmid. At least 2 μg of 
both pBluescript-ECM14 and pSLS1 were thoroughly digested with BamHI to ensure 
adequate recovery yields for future downstream applications. For pBluescript-ECM14, 12 
μl of pBluescript-ECM14 plasmid (170 ng/μl) was combined with 32 μl of sterile Milli-Q 
water, 5 μl of CutSmart Buffer, and 1 μl of BamHI-HF enzyme. For pSLS1, 7 μl of pSLS1 
plasmid (300 ng/μl) was combined with 37 μl of sterile Milli-Q water, 5 μl of CutSmart 
Buffer, and 1 μl of BamHI-HF enzyme. Both digestion reactions were allowed to incubate 
for >5 hours at 37°C. The pSLS1-BamHI digest was additionally treated with 2 μl of Calf 
Intestinal Alkaline Phosphatase (CIAP) to remove 5’ terminal phosphate groups and, thus, 
prevent vector re-circularization during subsequent ligation reactions. Both digests were 
electrophoresed in a 0.8% agarose gel (0.5 μg/ml EtBr) for 60 minutes in order allow for 
sufficient separation of the pBluescript (2,961-bp) and ECM14 (1,883-bp) bands. The 
pSLS1 and ECM14 bands were both gel extracted using the modified protocol for large 
DNA fragments, ran in an additional 0.8% agarose gel (0.5 μg/ml EtBr), and quantified 
using ImageJ.  
The pSLS1-ECM14 ligation reaction was performed overnight at 16°C with a 1:3 
vector-to-insert ratio. This ligation reaction contained 5 μl of ECM14-BamHI (20 ng/μl, 
0.081 pmol), 2 μl of pSLS1-BamHI-CIAP (94 ng/μl, 0.026 pmol), 10 μl of sterile Milli-Q 
water, 2 μl of T4 DNA Ligase Buffer, and 1 μl of T4 DNA Ligase. An additional ligation 
reaction lacking ECM14-BamHI was also performed as a test for CIAP treatment efficacy. 
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Additionally, the pSLS1-ECM14 ligation reaction was further diluted 5X as recommended 
by the Invitrogen Max Efficiency™ DH5α transformation protocol. 
A fresh 200-μl aliquot of Invitrogen Max Efficiency DH5α was slowly thawed on 
wet ice, split into four 50-μl aliquots, and gently mixed with either 5 μl of the pSLS1-
ECM14 ligation reaction, 5 μl of the 5X dilution, 5 μl of the CIAP ligation control, or 1 μl 
of pUC19 control plasmid. Each transformation mixture was incubated on wet ice for 30 
minutes, heat shocked at 42°C for 45 seconds, and returned to wet ice for 2 minutes. Each 
reaction was incubated for 60 minutes at 37°C in 450 μl of fresh SOC without ampicillin 
to allow for adequate expression of the ampicillin resistance gene prior to plating. These 
outgrowth cultures were subsequently plated on dry LB agar plates (250 μl/plate) with 
ampicillin and incubated at 37°C overnight for >20 hours. The pUC19 control 
transformation was plated on dry IPTG/X-Gal LB agar plates with ampicillin.  
Twelve putative pSLS1-ECM14 colonies were cultured overnight and miniprepped 
using the NID method. Nine putative pSLS1-ECM14 plasmids (1, 3, 4, 5, 6, 7, 8, 11 and 
12) were randomly selected and digested with BamHI-HF at 37°C for 60 minutes. Each of 
these diagnostic digests included 5 μl of plasmid DNA, 12 μl of sterile Milli-Q water, 2 μl 
of CutSmart Buffer, and 1 μl of BamHI-HF enzyme. Each digest was electrophoresed in a 
0.8% agarose gel (0.5 μg/ml EtBr) and imaged using the AlphaImager HP gel imaging 
system (see Figure 18). Only those digests that clearly liberated both a pSLS1 band (10.8-
kb) and an ECM14 band (1,883-bp) were considered for further interrogation (1, 3, 5, and 
7). The remaining digests (4, 6, 8, 11, and 12) contained a pBluescript band (2,961-bp) 
instead of a pSLS1 band and were discarded. 
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Figure 18. Cloning of wild-type ECM14 from pBluescript-ECM14 into pSLS1. 
The sequenced-verified ECM14 gene insert was subcloned from the pBluescript-
ECM14 (4.8 kb) parent plasmid into the pSLS1 (10.8 kb) destination vector. Nine 
putative pSLS1-ECM14 preparations were screened using a BamHI diagnostic 
digest. Only those digests that clearly liberated both a pSLS1 band (10.8 kb) and 
an ECM14 band (1.9 kb) were considered for further interrogation (*). 
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Determination of ECM14 Insert Orientation in pSLS1-ECM14 
A sequential diagnostic restriction digest with SmaI and EcoRI was performed in 
order to determine the orientation of the ECM14 gene insert in pSLS1-ECM14. Because 
only a single restriction enzyme was used during the original subcloning procedure, either 
insert orientation was equally probable. Although the ECM14 gene insert includes both 
endogenous promotor and terminator sequences (and, thus, should be transcribable in either 
orientation), it was still desirable to document the orientation for future reference. 
SmaI and EcoRI were intentionally chosen for this experiment based on two 
underlying assumptions: 1) SmaI cuts only within the parent vector and 2) EcoRI cuts 
asymmetrically within the gene insert. [These two basic assumptions can be applied to 
similar experiments.] The restriction sites within the ECM14 insert sequence produced by 
this study were mapped using EMBOSS Restrict (Hancock & Bishop, 2014) and SnapGene 
(from GSL Biotech; available at snapgene.com). It was noted that EcoRI cuts the ECM14 
insert sequence 378 bases from one end. 
Due to incompatible incubation temperatures, the SmaI digest was performed first 
at the lower temperature of 25°C (5 μl of plasmid DNA, 12 μl of sterile Milli-Q water, 2 
μl of CutSmart Buffer, and 1 μl of SmaI enzyme). The EcoRI digest was performed next 
at 37°C (5 μl of plasmid DNA, 12 μl of sterile Milli-Q water, 2 μl of CutSmart Buffer, and 
1 μl of EcoRI-HF enzyme). Each diagnostic digest was thoroughly incubated for >1 hour. 
Each diagnostic digest was combined with 4 μl of New England Biolabs’ Gel Loading Dye, 
Purple (6X), ran in a 0.8% agarose gel (0.5 μg/ml EtBr) at 100V until sufficient band 
separation, and imaged using the AlphaImager HP gel imaging system (see Figure 19). 
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Figure 19. Determination of ECM14 insert orientation in pSLS1-ECM14. 
A sequential diagnostic restriction digest with SmaI and EcoRI was performed in 
order to determine the orientation of the ECM14 gene insert in pSLS1-ECM14. 
 
The complete restriction map for the pSLS1 plasmid was recreated in silico using 
the original plasmid construction workflow reported by Barbour et al. (2000). It was noted 
in a personal communication with Steve Brill (Rutgers University, Piscataway, N.J.) that 
the pJM555 plasmid that was used as the ADE3 fragment source by Barbour et al. (2000) 
is now internally called pJM2555. Additional personal communications with Melanie 
Dobson (Dalhousie University, Nova Scotia, Canada), Doug Koshland (University of 
California, Berkeley, California), and Steve Henikoff (Fred Hutchinson Cancer Research 
Center, Seattle, Washington) further corroborated the sequence of the original pSLS1 map 
and its constituent gene fragments. 
The sequence-complete pSLS1 map revealed an EcoRI site at position 5,605 
(downstream of the SmaI cloning site at position 5,595) that was previously undocumented 
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by Barbour et al. (2000). Therefore, the EcoRI double digest with SmaI that was performed 
in this study was unnecessary. Besides an additional 10-bp SmaI-EcoRI fragment, a single 
EcoRI digest would have produced nearly identical restriction fragments (see Figure 20). 
 
Figure 20. A truncated segment of the sequence-complete pSLS1 map showing 
the previously undocumented EcoRI site at position 5,605. 
The ECM14 insert sequence produced by this study and the orientation data were 
merged with the newly constructed pSLS1 map using SnapGene to produce the novel 
recombinant pSLS1-ECM14 maps for both insert orientations (see Figure 21). The 
orientation nomenclature of pSLS1-ECM14 was defined according to the direction of 
ECM14 transcription relative to the GAL1 promotor (plus in the same direction; minus in 




Figure 21. Diagrams of the original pSLS1 vector and both orientations of the 
novel pSLS1-ECM14 recombinant plasmid. 
(A) The original pSLS1 plasmid contains the bacterial origin of replication 
sequence (ORI), the ampicillin resistance gene (AmpR) for selection in bacteria, 
the CEN/ARS sequence for replication in yeast, the URA3 gene for selection in 
yeast, and the ADE3 gene for color-colony reporting (Barbour et al., 2000; Xiao, 
2006). The CEN sequence is under the influence of the GAL1 galactose promotor. 
(B, C) The recombinant pSLS1-ECM14 plasmids containing either ECM14 insert 
orientation. Only the minus insert orientation was used for this study as this ECM14 
ORF is transcribed away from the CEN/ARS region. Only plasmid features relevant 
to this study are annotated (*). 
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QuikChange Site-Directed Mutagenesis of ECM14 
QuikChange site-directed mutagenesis (SDM) was used to introduce targeted 
changes to the wild-type ECM14 ORF. Because QuikChange SDM is more efficient with 
smaller plasmid constructs, the Sanger-sequenced pBluescript-ECM14 (4.8-kb) plasmid 
was selected instead of the larger pSLS1-ECM14 (12.7-kb) plasmid as the template 
harboring the wild-type ECM14 sequence to be mutagenized (see Table 2). QuikChange 
SDM operates on the functional principles of PCR using complementary mutagenic 
primers harboring 13-20 bp of homology, the mutation of interest (1-3 bp), and another 13-
20 bp of homology (see Table 1). Because the sense and antisense mutagenic primers are 
typically complementary (3’ overhangs are generally recommended), QuikChange SDM is 
inherently quite inefficient because these primers can erroneously self-anneal and produce 
primer dimers. Finally, the original parent plasmid is degraded prior to transformation and 
amplification in E. coli using the restriction enzyme DpnI, which selectively digests 
methylated dsDNA (PCR synthesized dsDNA is not methylated) (see Figure 22). 
 
 Figure 22. The basic QuikChange site-directed mutagenesis workflow. 
A parent plasmid harboring the wild-type sequence to be mutated is extended using 
PCR with complementary mutagenic primers that introduce a 1-3 bp substitution. 
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Three ECM14 residues were selected for QuikChange SDM: H69, H145, and K270 
(see Table 3). These three residues/positions were chosen based on their conservation and 
demonstratable relevance in catalytically active MCP orthologs: one selected as being 
critical for zinc binding (H69), one selected for substrate binding (R145), and one selected 
for catalysis (E270). The positively charged side chain of histidine (H69 and H196) is 
fundamentally required for proper zinc coordination in catalytically active MCP orthologs. 
Therefore, the ECM14-H69A mutant specifically disrupts this predicted zinc coordination 
by substituting this histidine (H) for an alanine (A), a small and uncharged amino acid. 
Because histidine and arginine (R) are both positively charged, the ECM14-H145A mutant 
specifically disrupts predicted substrate binding by replacing this conserved, positively 
charged residue with a small and uncharged alanine residue. Finally, because the 
glutamate (E) at position 270 is required for catalysis in active MCP orthologs, the 
ECM14-K270E and ECM14-K270A mutants specifically interrogate the relevance of the 
lysine (K) at this position in wild-type Ecm14. 
All mutagenic primers were ordered from Thermo Fisher Scientific (see Table 1) 
and reconstituted with Buffer EB (10 mM Tris-Cl, pH 8.5) to 100 μM. These reconstituted 
primers were further diluted to a final working concentration of 10 μM before being used 
in QuikChange SDM PCR reactions. The high-fidelity Platinum SuperFi DNA Polymerase 
from Invitrogen was used to perform the QuikChange SDM. A PCR master mix was 
prepared for n+1 reactions (n=4) by combining 142.5 μl of sterile Milli-Q water, 50 μl of 
5X SuperFi buffer, 25 μl of 2 mM dNTP mix, and 2.5 μl of SuperFi DNA Polymerase (2 
U/μl). The Sanger-sequenced pBluescript-ECM14 parent plasmid stock was diluted to a 
working concentration of 0.2 ng/μl (1 μl being used per SDM reaction). The amount of 
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parent pBluescript-ECM14 plasmid was minimized to ensure a high mutagenesis 
efficiency and thorough DpnI digestion prior to transformation. Forward and reverse 
mutagenic primers were added to a final concentration of 0.5 μM.  Because of the inherent 
inefficiencies of QuikChange SDM, three separate attempts with varying reaction 
conditions were performed in order to successfully produce the four desired ECM14 
mutants. The location of each site to be mutagenized was mapped and visualized on the 
pBluescript-ECM14 map using SnapGene (see Figure 23). 
 
 Figure 23. Locations for site-directed mutagenesis of pBluescript-ECM14. 
The pBluescript-ECM14 plasmid was used instead of the pSLS1-ECM14 plasmid 
as the template for site-directed mutagenesis due to its smaller size. Relevant primer 
binding sites are annotated (H69A, H145A, K270A, and K270E). Only plasmid 
features relevant to this study are shown (*). 
67 
The first SDM attempt was performed using a non-traditional two-step thermal 
cycling protocol as recommended in the SDM application note for Platinum SuperFi DNA 
Polymerase. The following two-step thermal cycling profile was performed: initial 
denaturation at 98°C for 30 seconds, followed by 30 cycles of denaturation at 98°C for 10 
seconds and a combined annealing-extension at 72°C for 2 minutes and 40 seconds (≈ 30 
sec/kb). The profile was completed with a final extension at 72°C for 5 minutes. The parent 
plasmid was digested by adding 1 μl of New England Biolabs’ DpnI restriction enzyme to 
each reaction and incubating in the thermal cycler heat block for 1 hour at 37°C. 
The second and third SDM attempts were performed using the more traditional 
three-step thermal cycling protocol. For the second SDM attempt, the following three-step 
thermal cycling profile was performed: initial denaturation at 98°C for 30 seconds, 
followed by 30 cycles of denaturation at 98°C for 10 seconds, annealing at 63°C for 10 
seconds, and extension at 72°C for 2 minutes and 40 seconds (≈ 30 sec/kb). The profile 
was completed with a final extension at 72°C for 5 minutes.  Additionally, the third SDM 
attempt also included 3% dimethyl sulfoxide (DMSO) in the PCR master mix to help 
discourage secondary structure formation in the template DNA. Consequently, because 
DMSO is known to lower primer melting temperatures, an annealing temperature of 59°C 
was utilized for the third SDM attempt. Like the first SDM attempt, the parent plasmids 
were digested by adding 1 μl of New England Biolabs’ DpnI restriction enzyme to each 
reaction and incubating in the thermal cycler heat block for 1 hour at 37°C.  
A portion of each DpnI-treated reaction (15 μl) was combined with 3 μl of New 
England Biolabs’ Gel Loading Dye, Purple (6X) and ran in a 0.8% agarose gel (0.5 μg/ml 




Figure 24. QuikChange site-directed mutagenesis of pBluescript-ECM14. 
Three QuikChange SDM attempts were required to successfully produce the four 
desired ECM14 mutants. The K270E mutant was successfully synthesized in the 
first attempt; K270E and H145A in the second attempt; and K270A and H69A in 
the third attempt (K270E and H145A were not attempted in the third attempt). PCR 




Four 50-μl aliquots of Invitrogen Subcloning Efficiency DH5α Competent Cells 
were slowly thawed on wet ice and each mixed with 5 μl of a DpnI-treated SDM reaction. 
Each transformation mixture was incubated on wet ice for 30 minutes, heat shocked at 
42°C for 45 seconds, and returned to wet ice for 5 minutes. Each reaction was incubated at 
37°C for 60 minutes in 200 μl of fresh LB without ampicillin to allow for adequate 
expression of the ampicillin resistance gene prior to plating. These outgrowth cultures were 
subsequently plated on dry LB agar plates with ampicillin, incubated at 37°C overnight for 
>20 hours, and screened for colonies. All four transformations yielded several colonies. 
In order to potentially improve the effectiveness and resolution of downstream 
Sanger sequencing, the Qiagen QIAprep® Spin Miniprep Kit was used instead of the 
cheaper NID method for extracting and purifying each putative mutant pBluescript-
ECM14 plasmid. Two monoclonal colonies from each transformation plate were used to 
inoculate 4 ml of LB/Amp and each culture was incubated overnight for 16-18 hours at 
37°C with shaking at 250 RPM. Each overnight culture was pelleted at 6,800g for 3 minutes 
and resuspended in 250 μl of Buffer P1. Each Buffer P1 suspension was mixed with 250 
μl of Buffer P2 and incubated at 25°C for 4 minutes. Immediately following incubation, 
these cell lysis reactions were thoroughly mixed with 350 μl of Buffer N3. Each of these 
neutralized reactions were centrifuged at 17,900g for 10 minutes to pellet cellular debris. 
Supernatants were transferred to a QIAprep spin column and centrifuged at 17,900g for 60 
seconds. The flow-through was discarded. Each spin column was then washed with 500 μl 
of Buffer PB and centrifuged at 17,900g for 60 seconds. The flow-through was discarded. 
Finally, each spin column was washed with 750 μl of Buffer PE and centrifuged for 
17,900g for 60 seconds. The flow-through was discarded. Any residual Buffer PE was 
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thoroughly removed with an additional round of centrifugation at 17,900g for 60 seconds. 
Plasmid DNA was eluted by carefully applying 50 μl of warm Buffer EB (55-65°C) to the 
center of each spin column and allowing each to incubate at room temperature for >5 
minutes. Each spin column was placed into a clean 1.5-ml microcentrifuge tube and 
centrifuged for 90 seconds at 21,130g to elute the plasmid DNA. 
Sanger sequencing was performed by GenScript (Piscataway, N.J.). The four 
putative mutant pBluescript-ECM14 plasmids were sequenced using the T7, T3, and 
ECM14_Internal primers (see Table 1) to ensure adequate sequencing coverage of the 
ECM14 gene insert. Three sequencing samples for each plasmid were prepared by 
premixing 10 μl of plasmid DNA (>50 ng/μl), 2.5 μl (50 pmol) of primer (either T7, T3, or 
ECM14_Internal), and 2.5 μl of sterile Milli-Q water. Samples were shipped overnight in 
1.5-ml microcentrifuge tubes sealed with Parafilm. [An initial attempt at sequencing the 
putative mutant pBluescript-ECM14 plasmids was performed using the ECM14_A and 
ECM14_D primers. However, these sequencing runs were inconclusive.] 
Sequencing results were first processed by visually inspecting the chromatograms 
using either Chromas or UGENE for base call quality and subsequently truncating any poor 
terminal sequence as necessary. Each sequence was then aligned with the wild-type 
ECM14 reference sequence produced by this study. Complete, end-to-end sequencing 
coverage of each mutant ECM14 gene was not achieved. However, the mutagenized site 
for each was successfully sequenced and, thus, provided adequate confirmation that each 
of the four desired mutations were present (see Figure 25, Figure 26, and Figure 27). 
Finally, each mutant ECM14 gene was subcloned into pSLS1 and the resulting insert 




Figure 25. Confirmation of successful ECM14-H69A SDM 
Three putative pBluescript-ECM14-H69A plasmids were sequenced using the T7, 
T3, and ECM14_Internal primers (see Table 1) to ensure adequate sequencing 
coverage of the ECM14 gene insert. Only the sequence and chromatograms of the 
28-30 bases around mutagenic site are shown. (A) Wild-type pBluescript-ECM14 
was used as a “before SDM” control. (B) The resultant “after SDM” mutagenized 
ECM14 sequence. The codon of interest is annotated in both sequences and the 





Figure 26. Confirmation of successful ECM14-H145A SDM. 
Three putative pBluescript-ECM14-H145A plasmids were sequenced using the T7, 
T3, and ECM14_Internal primers (see Table 1) to ensure adequate sequencing 
coverage of the ECM14 gene insert. Only the sequence and chromatograms of the 
28-30 bases around mutagenic site are shown. (A) Wild-type pBluescript-ECM14 
was used as a “before SDM” control. (B) The resultant “after SDM” mutagenized 
ECM14 sequence. The codon of interest is annotated in both sequences and the 





Figure 27. Confirmation of successful ECM14-K270[A/E] SDM. 
Three putative pBluescript-ECM14-K270[A/E] plasmids were sequenced using the 
T7, T3, and ECM14_Internal primers (see Table 1) to ensure adequate sequencing 
coverage of the ECM14 gene insert. Only the sequence and chromatograms of the 
28-30 bases around mutagenic site are shown. (A) Wild-type pBluescript-ECM14 
was used as a “before SDM” control. (B, C) The resultant “after SDM” 
mutagenized ECM14 sequence. The codon of interest is annotated in both 
sequences and the resultant amino acid identified. Codons are reverse-complement 




Three minus orientations of each of the four mutant pSLS1-ECM14 plasmids were 
miniprepped using the Qiagen QIAprep Spin Miniprep Kit (H69A_1, H69A_3, H69A_6; 
H145A_13, H145A_14, H145A_16; K270A_1, K270A_5, K270A_6; and K270E_6, 
K270E_7, K270E_11). The mutated site in each plasmid was Sanger sequenced by 
Genscript using only a single primer. The ECM14_Internal primer was used to sequence 
the H69A and H145A sites; and the ECM14_D primer was used to sequence the K270A 
and K270E sites (see Table 1). Because the high-fidelity Platinum SuperFi DNA 
Polymerase was used to perform the original site-directed mutagenesis in 
pBluescript-ECM14, it was not necessary to re-sequence the entire mutant ECM14 gene. 
However, the purpose of this final round of Sanger sequencing was simply to validate the 
subcloning of each mutant ECM14 gene from pBluescript into pSLS1 (see Table 2). 
The mutated sites in H145A_13, H145A_14, H145A_16, K270A_1, K207A_5, and 
K270E_11 were successfully sequenced and confirmed. However, the remaining samples 
were inconclusive due to failed sequencing runs that Genscript was unable to resolve by 
simply tweaking the sequencing conditions and re-running these failed runs. However, 
those successful mutant pSLS1-ECM14 sequences, along with the successful mutant 
pBluescript-ECM14 sequences, provided confidence that the subcloning of each mutant 
ECM14 sequence from pBluescript to pSLS1 was successful.  
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CHAPTER 4 
YEAST STRAIN CONSTRUCTION METHODS AND RESULTS 
The Yeast Gene Deletion Strategy 
The primary method for deleting genes in the yeast genome is the mechanism of 
chromosomal integration by homologous recombination (HR) (see Figure 28). Because 
point and non-sense mutations can spontaneously revert (producing so-called revertants), 
removing the entire gene by HR is a more effective method for permanently deleting genes. 
The first step in yeast gene deletion involves a polymerase chain reaction (PCR) in 
order to amplify and extend a plasmid-borne MX sequence with 45-bp upstream and 
downstream extensions flanking your favorite gene (YFG). These unique upstream and 
downstream extensions are critical for ensuring that HR occurs over the intended genomic 
interval. These MX “expression” cassettes also include the powerful, always-on promotor 
(PTEF) and terminator (TTEF) sequence derived from the heterologous Ashbya gossyppi TEF 
gene. Finally, subsequent diagnostic PCR reactions are performed in order to interrogate 
both the location and the size the MX allele in the yeast genome. In general, this approach 
can be used to replace any non-essential yeast gene with a variety of drug resistance (e.g. 
Geneticin/Kanamycin, Nourseothricin, etc.) or autotrophic (e.g. LEU2, TRP1, URA3, etc.) 
selection markers (Baudin et al., 1993; Wach et al., 1994). 
The commercially available Yeast Knock-out (YKO) Collection was produced by 
selectively replacing, via this process of chromosomal integration by homologous 
recombination, each of the ≈5,000 non-essential genes with the Geneticin® resistance MX 
cassette (KanMX). The original ecm14Δ clones used in this investigation were derived 
from the YKO collection. 
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Figure 28. The yeast gene deletion strategy. 
The mechanism of chromosomal integration by homologous recombination. 1) 
PCR is first performed in order to amplify and extend a plasmid-borne MX 
sequence with 45-bp upstream and downstream extensions flanking your favorite 
gene (YFG). These MX “expression” cassettes include the powerful, always-on 
promotor (PTEF) and terminator (TTEF) sequence derived from the heterologous 
Ashbya gossyppi TEF gene. 2) Yeast are then transformed with this deletion 
cassette. 3) Finally, PCR reactions using either the A or MX_C (*) upstream 
primers are performed that interrogate both the location and the size of the MX 
allele in the yeast genome. (DNA features are not drawn to scale.)  
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High-Fidelity PCR Amplification of [ecm14::KanMX] Cassette 
The [ecm14::KanMX] deletion cassette was PCR amplified from an ecm14Δ 
knockout S288C-derived yeast strain (BY4741) obtained from the Yeast Knockout 
Collection (YKO) (Baker Brachmann et al., 1998). The high-fidelity Platinum SuperFi 
DNA Polymerase from Invitrogen was used to amplify the [ecm14::KanMX] deletion 
cassette. A PCR master mix was prepared for n+1 reactions (n=2) by combining 73 μl of 
sterile Milli-Q water, 30 μl of 5X SuperFi buffer, 15 μl of 2mM dNTP mix, 2.5 μl of 
ECM14_A primer, 2.5 μl of ECM14_D primer, and 2 μl of SuperFi DNA Polymerase (2 
U/μl). Either 5 μl of wild-type Y1239 gDNA or ecm14Δ S288C gDNA was used as 
template DNA to a final volume of 50 μl per reaction. Forward and reverse primers were 
added to a final concentration of 0.5 μM. Each reaction tube was capped and carefully 
mixed before placing into a Bio-Rad T100 Thermal Cycler. Forty PCR cycles were 
performed using the following thermal profile: initial denaturation at 98°C for 30 seconds, 
thermocycling denaturation at 98°C for 10 seconds, thermocycling annealing at 63.6°C for 
10 seconds, thermocycling extension at 72°C for 60 seconds, and final extension at 72°C 
for 5 minutes. Each PCR reaction was combined with 10 μl of New England Biolabs’ Gel 
Loading Dye, Purple (6X) and ran in a 0.8% agarose gel (0.5 μg/ml EtBr) for visualization 
and gel extraction/cleanup.  
Wild-type Y1239 gDNA was used as a control and produced a single, strong 1.9-
kb wild-type ECM14 amplicon. The ecm14Δ knockout gDNA produced a single, strong 




Figure 29. PCR Amplification of the ecm14::KanMX deletion cassette. 
The ecm14::KanMX deletion cassette was PCR amplified from an ecm14Δ 
knockout S288C yeast strain obtained from the Yeast Knockout Collection (YKO). 
The high-fidelity Platinum SuperFi DNA Polymerase from Invitrogen was used to 
amplify the ecm14::KanMX deletion cassette (2.2 kb). Wild-type Y1239 yeast was 




Transformation of AF-1A/D Yeast with [ecm14::KanMX] Cassette 
Fresh monoclonal colonies of either AF-1A or AF-1D (MATα and MATa, 
respectively) were used to inoculate 10 ml of YEPD media (see Table 4). Liquid cultures 
were incubated overnight at 30°C with shaking at 250 RPM. Cultures were grown to 1-
2x108 cells/ml, diluted to 2x106 cells/ml in 50 ml of fresh YEPD media, and returned to 
incubation at 30°C with shaking at 250 RPM for an additional 2-3 hours (≈2 cell divisions). 
These diluted cultures were grown to 0.7-1.5x107 cells/ml. Each culture was then 
transferred into a sterile 50-ml falcon tube and centrifuged for 5 minutes at 4,000 g. Each 
pellet was then decanted, resuspended in sterile water, and centrifuged for an additional 5 
minutes. 
Pellets were resuspended in 1 ml of filter-sterilized 1X TE/LiAc, transferred to a 
1.5-ml microcentrifuge tube, centrifuged for 6 minutes at 4,000 g, and resuspended in 250 
μl of 1X TE/LiAc. Double stranded salmon sperm DNA was denatured at 100°C for 5 
minutes and placed on wet ice. Yeast transformation mixtures contained 5 μl of single-
stranded salmon sperm DNA, 15 μl of [ecm14::KanMX] PCR product, 50 μl of yeast 
suspension, and 300 μl of 1X PEG/TE/LiAc (reagents were added in this order). Each 
transformation mixture was thoroughly vortexed, incubated at 30°C for 30 minutes, and 
heat-shocked at 42°C for 20 minutes. Each mixture was then briefly centrifuged at 21,130 
g for 10 seconds, the PEG/TE/LiAc supernatant promptly removed, and the cells washed 
in 0.5 ml of sterile water. Pellets were resuspended in fresh YEPD media and incubated at 
30°C for 2 hours to allow for adequate KanMX gene expression. These outgrowth cultures 
were then briefly centrifuged at 21,130 g for 10 seconds, the YEPD media removed, and 
80 
resuspended in 100 μl of sterile water. Finally, yeasts were plated on dry YEPD agar plates 
with Geneticin, incubated at 30°C for 2-3 days, and stored at 4°C. 
Putative AF1-A/D [ecm14::KanMX] colonies from both transformation plates were 
streaked out for single colonies onto fresh YEPD agar plates with Geneticin and incubated 
at 30°C for 2-3 days. Putative monoclonal AF-1A/D [ecm14::KanMX] colonies were 
grown in 1 ml YEPD overnight to mid-log phase (1-5x107 cells/ml, OD600 = 0.4-1.7). 
Genomic DNA was extracted from 0.2 ml of each overnight culture. Frozen glycerol stocks 
were also made by combining 0.5 ml of each overnight culture with 0.5 ml of sterile 
glycerol (50% v/v) in 1-ml cryogenic storage tubes and stored at -80°C. 
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Low-fidelity PCR Genotyping of Putative AF-1A/D ecm14Δ Clones 
Putative AF1-A/D [ecm14::KanMX] clones were screened for both the presence of 
the KanMX ORF and the absence of the ECM14 ORF using the low-fidelty DreamTaq™ 
DNA polymerase from Thermo Fisher Scientific. Either the upstream ECM14_A or Kan_C 
upstream primer was used with the downstream ECM14_D primer (see Table 1). The 
Kan_C primer is specific for the KanMX ORF and is expected to produce an 888-bp 
amplicon when used with the downstream ECM14_D primer. However, the ECM14_A 
and ECM14_D primers are expected to produce either an 1,894-bp amplicon in wild-type 
yeast or an 2,185-bp amplicon in ecm14Δ yeast. 
A PCR master mix was prepared for n+1 reactions (n=7) by combining 251.5 μl of 
sterile Milli-Q water, 35 μl of 10X DreamTaq buffer, 35 μl of 2mM dNTP mix, 8.75 μl of 
Kan_C primer, 8.75 μl of ECM14_D primer, and 3 μl of DreamTaq DNA polymerase (5 
U/μl). An additional PCR master mix was prepared with ECM14_A and ECM14_D 
primers. Either 1 μl of gDNA from AF-1A_3, AF-1D_5, AF-1D_6, or AF-1D_7 was used 
as template DNA. Additionally, either 1 μl of gDNA from wild-type Y1239 or ecm14Δ 
S288C were used as controls. Forward and reverse primers were added to a final 
concentration of 0.2 μM. Each reaction tube was capped and carefully mixed before placing 
into a Bio-Rad T100 Thermal Cycler. Forty PCR cycles were performed using the 
following thermal profile: initial denaturation at 95°C for 30 seconds, thermocycling 
denaturation at 95°C for 30 seconds, thermocycling annealing at 57°C for 30 seconds, 
thermocycling extension at 72°C for 60 seconds, and final extension at 72°C for 5 minutes. 
Each PCR reaction was combined with 10 μl of New England Biolabs’ Gel Loading Dye, 
Purple (6X) and ran in a 0.8% agarose gel (0.5 μg/ml EtBr) (see Figure 30). 
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Figure 30. Knock-out yeast strains were constructed using the ecm14::KanMX 
deletion cassette and were verified using low-fidelity PCR. 
Both mating types (AF-1A and AF1-D) were transformed using the 
[ecm14::KanMX] deletion cassette and verified using PCR reactions that 
interrogate both the size and the location of the KanMX allele. (A, B) Successful 
ECM14 deletion can be verified by screening for a 2.2-kb KanMX amplicon or a 
1.9-kb ECM14 amplicon (C). Successful ECM14 deletion can also be verified by 
screening for a 0.9-kb Kan_C + ECM14_D amplicon (A, D). The YKO ecm14 
knockout (Δ) was used as a Kan_C positive control. Wild-type Y1239 lack the 
KanMX allele (B, D). 
 
Those successful AF-1A/D [ecm14::KanMX] clones were streaked for single 
colonies from glycerol stocks onto YEPD agar plates with Geneticin and incubated at 30°C 
for 2-3 days for future transformation reactions. The successful AF-1A_3 and AF-1D_2 
clones were renamed to CM-1A_3 and CM-1D_2 respectively (see Table 4). 
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Transformation of CM-1A/D ecm14Δ Yeast with pSLS1-ECM14 
Fresh monoclonal colonies of either CM-1A_3 [ecm14::KanMX] or CM-1D_2 
[ecm14::KanMX] (MATα and MATa, respectively) were used to inoculate 10 ml of YEPD 
media. Liquid cultures were incubated overnight at 30°C with shaking at 250 RPM. 
Cultures were grown to 1-2x108 cells/ml, diluted to 2x106 cells/ml in 50 ml of fresh YEPD 
media, and returned to incubation at 30°C with shaking at 250 RPM for an additional 2-3 
hours (≈2 cell divisions). Diluted cultures were grown to 0.7-1.5x107 cells/ml. Each culture 
was transferred into a sterile 50-ml falcon tube and centrifuged for 5 minutes at 4,000 g. 
Each pellet was then decanted, resuspended in sterile water, and centrifuged for an 
additional 5 minutes.  
Pellets were resuspended in 1 ml of filter-sterilized 1X TE/LiAc, transferred to a 
1.5-ml microcentrifuge tube, centrifuged for 6 minutes at 4,000 g, and resuspended in 250 
μl of 1X TE/LiAc. Double stranded salmon sperm DNA was denatured at 100°C for 5 
minutes and placed on wet ice. Yeast transformation mixtures contained 5 μl of single-
stranded salmon sperm DNA, 2 μl of either orientation of pSLS1-ECM14, 50 μl of yeast 
suspension, and 300 μl of 1X PEG/TE/LiAc (reagents were added in this order). Each 
transformation mixture was thoroughly vortexed, incubated at 30°C for 30 minutes, and 
heat-shocked at 42°C for 20 minutes. Each mixture was then briefly centrifuged at 21,130 
g for 10 seconds, the PEG/TE/LiAc supernatant promptly removed, and washed in 0.5 ml 
of sterile water. Pellets were resuspended in fresh YEPD media and incubated at 30°C for 
2 hours to allow for adequate KanMX gene expression. These outgrowth cultures were 
then briefly centrifuged at 21,130 g for 10 seconds, the YEPD media removed, and 
resuspended in 100 μl of sterile water.  
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Outgrowth cultures were plated on dry SC-Ura agar plates, incubated at 30°C for 
3-4 days, and stored at 4°C. Minimal SC media lacking uracil (SC-Ura) was used to 
positively select for the pSLS1-ECM14 plasmid. Additionally, growth on both YEPD and 
YPGal were observed to demonstrate destabilization and loss of the plasmid when cultured 
under the influence of galactose (see Figure 31). 
 
Figure 31. Growth of CM-1A/D ecm14Δ [pSLS1-ECM14(±)] on various growth 
media to demonstrate plasmid transformation and plasmid destabilization. 
CM1-A/D ecm14Δ transformed with pSLS1-ECM14(±) was grown on SC-Ura, 
YEPD, and YPGal. Growth on SC-Ura positively selects for the pSLS1-ECM14(±) 
plasmid. Growth on YEPD and YPGal demonstrate plasmid destabilization prior to 
subsequent mutagenesis experiments. Growth on YPGal effectively destabilizes the 




THE SYNTHETIC LETHAL SCREEN METHODS AND RESULTS 
EMS Mutagenesis in Yeast 
 Fresh monoclonal colonies of either CM-1A_2 [pSLS1-ECM14, ecm14::KanMX] 
or CM-1D_3 [pSLS1-ECM14, ecm14::KanMX] (MATα and MATa, respectively) were 
used to inoculate 10 ml of SC-Ura media. Routine growth of these pre-mutagenesis strains 
was performed in/on SC-Ura to ensure strong selective pressure for the pSLS1-ECM14 
plasmid (see above Figure 31). Overnight cultures were adjusted to 2x108 cells/ml and 1 
ml of each culture was pelleted in a clean 1.5-ml microcentrifuge at 21,130g for 10 seconds. 
Pellets were washed twice in 1 ml of sterile water. After the second washing, pellets were 
resuspended in 1.5 ml of sterile sodium phosphate buffer (0.1M, pH 7.0). EMS mutagenesis 
was performed by combining 0.7 ml of cell suspension, 1 ml of sodium phosphate buffer, 
and 50 μl of EMS in a sterile 15-ml polypropylene culture tube and incubating at 30°C for 
45-60 minutes. The remaining cell suspensions were saved on wet ice as a pre-mutagenesis 
control. Mutagenesis was halted by adding 0.2 ml of EMS treated cells to a sterile culture 
tube containing 8 ml of sterile sodium thiosulfate solution (5% w/v). Nonmutagenized 
control cells were diluted equivalently as above by substituting EMS with sterile water. 
Both EMS-treated and untreated cell suspensions were serially diluted to 1-3 viable cells/μl 
for plating on various growth media (100-300 viable cells per plate at 100 μl plated 
volume). The EMS mutagenesis protocol used in this study was adapted from Winston 
(2008); and Barbour and Xiao (2006).  
Diluted EMS-treated and untreated cell suspensions were plated on various growth 
media, incubated at 30°C for 2-4 days, and stored at 4°C for several days to facilitate 
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adequate color development. YPD/YEPD plates were used as controls to determine the 
effectiveness of EMS mutagenesis and to tune EMS exposure time in subsequent 
mutagenesis attempts. An ideal EMS exposure should cause ≈40% of the cells to be killed 
(Winston, 2008). An EMS exposure time of 45 minutes was determined to be effective at 
generating the ideal cell death (≈40%) in the strains used in this study (see Figure 32).     
 
Figure 32. The effect of EMS exposure time on yeast cell viability. 
EMS-treated and untreated cells were plated on YPD/YEPD media to test the effect 
of EMS exposure at both 60 minutes and 45 minutes. Sixty minutes of exposure 
was ineffective at producing enough viable yeast cells per plate (84.3% cell death). 
Reducing the EMS exposure to 45 minutes was determined to be more effective at 
generating a more ideal cell death (43.6%) in the yeast strains used in this study.  
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As was previously demonstrated in this study, growth on YPGal was used to 
effectively destabilize the pSLS1-ECM14 plasmid and to screen for novel plasmid 
dependencies (see above Figure 31). However, because the pSLS1-ECM14 plasmid 
contains two additional yeast genes (ADE3 and URA3) (see above Figure 11), this 
approach is fundamentally unable to immediately identity false-positive synthetic lethal 
situations caused by a novel dependency on either the plasmid-borne ADE3 or URA3 genes. 
Synthetic lethal situations likely require that all genes involved are transcriptionally 
active. Therefore, effectively silencing either the ADE3 or URA3 gene could potentially 
improve the sensitivity of the synthetic lethal screen and decrease the number of false-
positives to be subsequently evaluated. Because an active, plasmid-borne ADE3 gene is 
fundamentally required for the ADE3/ADE2 color-colony assay essential to the synthetic 
lethal screen, any potential modifications to decrease ADE3 false-positives were not 
immediately available for use in this study. However, because the URA3 gene is not (and 
should not be) involved in the synthetic lethal screen and any subsequent color-colony 
assays, modifications were made in later mutagenesis attempts in order to potentially 
decrease these undesirable URA3 false-positives. Because the URA3 gene is effectively 
silenced when grown on media containing excess uracil, a modified YPGal media 
containing extra uracil (5 ml of sterile, 0.2% uracil per liter of media) was also used for 
screening EMS-treated cells. 
 In addition to the modification to potentially decrease URA3 false-positives, a 
modified YPGal media containing 20 μg/ml, filter-sterilized calcofluor white (1000X stock 
prepared at 20mg/ml) was also used for screening EMS-treated cells. Because exposure to 
calcofluor white (CFW) amplifies the effect of mutations in genes involved in cell wall 
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architecture and remodeling (Lussier et al., 1997; Ram et al., 1994), screening these EMS-
treated cells on media containing CFW was thought to increase the sensitivity of the 
synthetic lethal screen to resolving novel mutations in genes that are functionally related 
to ECM14. The concentration of CFW used in this modified YPGal media was based on 
the standard concentration used to generate CFW hypersensitive mutants by Lussier et al. 
(1997). Finally, a combination YPGal media containing both uracil and CFW was used in 
the later mutagenesis attempts in order to further encourage the generation of true ECM14 
synthetic lethal colonies. In either case, plates containing EMS-treated cells were screened 
for non-sectored, red colonies of interest to be further studied (see Figure 33).  
 
Figure 33. Screening EMS-treated cells on YPGal vs. YPGal+Ura+CFW. 
YPGal was used to effectively destabilize the pSLS1-ECM14 plasmid and to 
screen for novel plasmid dependencies. YPGal+Ura+CFW was used to discourage 
the generation of URA3 false-positives and to place additional pressure on genes 
thought to be functionally related to ECM14. All screening plates represented were 
plated with the same number of cells at the same time. Plates containing colonies 
of interest were those that contained at least one non-sectored red colony to be 
further evaluated as a putative synthetic lethal. 
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  Screening Putative ECM14 Synthetic Lethal Mutants 
Approximately 27,000 EMS-treated CM-1D ecm14Δ [pSLS1-ECM14(-)] yeast 
colonies were screened for novel plasmid dependencies on galactose media (either YPGal, 
YPGal+CFW, or YPGal+Ura+CFW). Three significant rounds of EMS mutagenesis were 
performed, with each yielding approximately 10,000 screenable EMS-treated yeast 
colonies. Colonies of interest were those that initially produced the desired non-sectored 
red phenotype on these media. These non-sectored red colonies of interest were noted and 
re-streaked for single colonies on fresh media to further evaluate the development and the 
maintenance of the desired non-sectored red phenotype. Colonies that initially appeared as 
white or sectored on galactose media were those that likely did not contain synthetic lethal 
mutations and, thus, were not considered for further evaluation. 
As recommended by Barbour and Xiao (2006), additional rounds of growth tests 
on both SC-Ura and SC+5FOA were attempted in order to test for true synthetic lethal 
mutants caused by novel secondary mutations or for potential false-positives caused by 
reversions of marker genes. True synthetic lethal mutants fundamentally require the 
plasmid for survival. Therefore, counterselection against the plasmid-borne URA3 gene 
using 5-FOA should result in plasmid loss and, thus, cell death for true synthetic lethal 
mutants. This prescribed test was performed on the first five putative synthetic lethal 
mutants (SL1-5) produced from the first significant round of EMS mutagenesis performed. 
A series of spotting assays was performed using serial 1:10 dilutions of these first 
five putative synthetic lethal mutants (SL1-5), one EMS-treated white non-synthetic lethal 
colony, and one untreated control strain. Although these five putative synthetic lethal 
mutants seemed to retain the desired phenotype when subsequently re-plated/spotted on 
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YPGal, all five were unable to appreciably grow on any SC-based media. However, 
because the EMS-treated white non-synthetic lethal colony (CM-1D ecm14Δ) and 
untreated control strain (CM-1D ecm14Δ [pSLS1-ECM14(-)]) were able to grow on SC-
based media, this apparent lack of growth of these synthetic lethal mutants seemed to have 
nothing to do with either the presence or the absence of the ECM14 gene (see Figure 34). 
Instead, this lack of growth seemed to be the result of the secondary mutations in these 
putative synthetic lethal mutants conferring significant fitness deficiencies on these SC-
based media. Therefore, these apparent fitness deficiencies suggest that counterselection 
of the pSLS1-ECM14 plasmid using SC+5FOA is likely not an informative diagnostic 
when assessing the quality of the putative synthetic lethal mutants produced in this study. 
 
Figure 34. Testing five putative synthetic lethal mutants on SC-Ura and SC+5FOA. 
Spotting assay on YPGal, SC-Ura, and SC+5FOA. Serial 1:10 dilutions of five 
putative synthetic lethal mutants (SL1-5), one EMS-treated white, non-synthetic 
lethal colony (W), and one untreated control strain (C). Plates were incubated at 
30°C for ≈120 hours. Putative synthetic lethal mutants were derived from EMS-
treated CM-1D ecm14Δ [pSLS1-ECM14(-)] colonies initially screened on YPGal. 
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All putative synthetic lethal mutants were re-streaked for single colonies on 
galactose media to further evaluate the development and maintenance of the desired 
phenotype. Those initial white non-synthetic lethal colonies always remained white when 
re-streaked on galactose media. However, many colonies of interest that initially produced 
the desired non-sectored red phenotype on these media following EMS treatment produced 





Figure 35. Re-streaking putative synthetic lethal mutants on galactose media. 
Putative synthetic lethal mutants that initially produced the desired non-sectored 
red phenotype were re-streaked for single colonies on galactose media to evaluate 
the development and maintenance of the red phenotype. (*) Colonies that were 




Non-sectored red colonies from these re-streaked galactose plates were used to 
inoculate 2 ml of YPD liquid culture. These cultures were incubated overnight at 30°C with 
shaking at 250 RPM. Frozen glycerol stocks were prepared by combining 500 µl of 50% 
(v/v) sterile glycerol and 500 µl of overnight culture in a cryovial tube and were stored 
at -80°C. Several non-sectored red colonies were used to prepare frozen glycerol stocks for 
multiple clones from the same re-streaked plate (see above Figure 35).  
The first round of EMS mutagenesis yielded five putative synthetic lethal mutants 
(SL1-5) derived from YPGal. The second round yielded two putative synthetic lethal 
mutants derived from YPGal+Ura+CFW (SL6-7) and six from YPGal (SL8-13). [SL14 
was discovered accidentally after rechecking EMS-screening plates that had been stored at 
4°C for many weeks.] The final round yielded eight putative synthetic lethal mutants 
derived from YPGal+Ura and YPGal+Ura+CFW (SL15-22). Due to both timing and 
logistical constraints, only those eight putative synthetic lethal mutants from the second 
round (SL6-13+14) were able to be considered for future whole-genome sequencing and 
bioinformatic analysis. Three clones from each of these eight putative synthetic lethal 
mutants were re-streaked in mass on YPD, YPGal+Ura, and YPGal+Ura+CFW to further 
evaluate the development and maintenance of the desired phenotype prior to selection for 
whole-genome sequencing (see Figure 36 and Figure 37). Seven putative synthetic lethal 
mutants (SL6, SL7, SL8, SL11, SL12, SL13, and SL14) were selected for whole-genome 
sequencing Those remaining eight putative synthetic lethal mutants (SL15-22) were noted 




Figure 36. Re-streaking putative synthetic lethal mutants (SL6-9) for the 
selection of candidates for whole-genome sequencing. 
Three clones (1-3) of each putative synthetic lethal mutant (SL6-9) were re-streaked 
on YPD, YPGal+Ura, and YPGal+Ura+CFW to further evaluate the development 
and maintenance of the desired phenotype prior to selection for whole-genome 
sequencing. An additional untreated control strain (C) (CM-1D ecm14Δ [pSLS1-
ECM14(-)]) was also streaked for comparison. 
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Figure 37. Re-streaking putative synthetic lethal mutants (SL10-13) for the 
selection of candidates for whole-genome sequencing. 
Three clones (1-3) of each putative synthetic lethal mutant (SL10-13) were re-
streaked on YPD, YPGal+Ura, and YPGal+Ura+CFW to further evaluate the 
development and maintenance of the desired phenotype prior to selection for 
whole-genome sequencing. An additional untreated control strain (C) (CM-1D 
ecm14Δ [pSLS1-ECM14(-)]) was also streaked for comparison. 
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CHAPTER 6 
BIOINFORMATICS METHODS AND RESULTS 
Whole-Genome Sequencing of Seven Putative Synthetic Lethal Yeast Strains 
 Fresh monoclonal colonies from seven putative synthetic lethal mutants (SL6, SL7, 
SL8, SL11, SL12, SL13, and SL14) and one wild-type, non-mutagenized yeast strain (all 
derived from CM-1D_3[ECM14(-)], see Table 4), were cultured overnight at 30°C with 
shaking in 3 ml of YEPD supplemented with 25 μl of 0.5% (w/v) filter-sterilized adenine 
solution. Cultures were grown to saturation. Each overnight culture was entirely pelleted 
in a clean 1.5-ml microcentrifuge tube and washed twice with sterile water. Each of the 
eight microcentrifuge tubes containing yeast cell pellets were thoroughly sealed with 
Parafilm and shipped on ice overnight to The Sequencing Center in Fort Collins, Colorado. 
 Next-generation whole-genome sequencing of all eight samples was performed by 
The Sequencing Center (TSC) using the Illumina MiniSeq® platform with a targeted mean 
coverage depth of ≈40-50× (see Table 5). The raw forward and reverse sequencing reads 
for each sample were returned from The Sequencing Center in the ubiquitous FASTQ file 
format for future bioinformatic analyses. [The FASTQ file format is the de facto standard 
for storing the output of high-throughput, next-generation sequencers. The FASTQ format 
stores both the biological sequence and the corresponding quality score for each called 
sequence letter.] The forward and reverse reads for each sample were paired to form 





W303 Genome Annotation and Reference-guided Genome Assembly 
 The Saccharomyces cerevisiae yeast strains constructed in this study were based 
on the W303 lineage. Therefore, an annotated W303 genome was desired. [Genome 
annotation is the process of identifying various genomic elements (e.g. introns, exons, 
regulatory sequences, coding regions, etc.) and linking useful biological metadata to these 
elements.] Although S288C and W303 are closely related, they differ enough to render 
comparative analyses and variant calling inordinately noisy and problematic. Ralser et al. 
(2012) reported that the W303 and S288C genomes differ in 8,133 nucleotide positions 
and 799 open reading frames. Despite these notable differences and some telomeric 
rearrangements (notably found on chromosome XI, XIII, and XVI), the overall landscape 
and structure of the S288C and W303 genomes are very similar (Matheson et al., 2017). 
The annotated S288C genome was downloaded from the NCBI Reference 
Sequence (RefSeq) database (Release 97, November 2019). The W303 genome has been 
thoroughly sequenced (Goodwin et al., 2015; Lang et al., 2013; Matheson et al., 2017; 
Ralser et al., 2012; Song et al., 2015). Recent high quality PacBio® W303 sequencing data 
(47.0× coverage) from Matheson et al. (2017) were downloaded from the NCBI GenBank 
database (LYZE01000001-21). Genome annotations were transferred from each S288C 
chromosome to their corresponding W303 chromosome using the BLAST-like “Annotate 
From…” alignment tool in Geneious Prime 2019.2.3 (see Figure 38). In order to decrease 
the computational time required to align all S288C annotation sequences against the W303 
genome, each W303 chromosome was annotated using only its corresponding S288C 
chromosome as the source database (instead of the entire S288C genome as the source 
database). Each annotated S288C chromosome was placed in separate folders that were 
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individually selected as the “Source” database when annotating each corresponding W303 
chromosome. Annotations were matched using a generous similarity index of 80%. 
Otherwise, the default “Annotate From…” tool parameters were used. 
 
Figure 38. An annotated portion of W303 chromosome VIII. 
An annotated portion of W303 chromosome VIII (376,500…380,500) that includes 
the ECM14 gene (green) and its corresponding coding sequence (yellow). The 
ECM14 CDS is found along the interval 377,832 to 376,531. Genome annotations 
from the S288C RefSeq genome were matched, transferred, and merged onto the 
W303 genome using Geneious Prime 2019.2.3. 
 
Those matched annotations were subsequently merged onto the W303 genome. 
Because the Geneious Prime “Annotate From…” tool only transfers annotations (and their 
associated biological metadata), the underlying nucleotide sequences remained intact and 
unmodified. These annotated W303 chromosomes were combined and exported as a new 
Geneious sequence list representing the entire W303 genome (17 sequences: 16 
chromosomes plus mitochondrial DNA) to be used in subsequent reference-guided genome 
assemblies and analyses. 
The paired reads for each putative synthetic lethal mutant and the wild-type, non-
mutagenized control yeast strain were mapped against this annotated W303 genome using 
the Geneious Prime “Map to Reference” tool to generate whole-chromosome assemblies 
for each sample  (see Table 5).  The default “Map to Reference” tool parameters were used 
(Mapper: Geneious Assembler; Sensitivity: Medium-Low Sensitivity / Fast; and Fine 
Tuning: Iterate up to 5 times). 
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Variant Calling, Filtering, and Analysis 
Genetic variants were called on each chromosome from each sequenced sample 
using the Geneious Prime “Annotate & Predict > Find Variations/SNPs…” tool (Minimum 
Coverage: 3; Minimum Variant Frequency: 0.8; Maximum Variant P-Value: 10-2; and Find 
Variants: Inside & Outside CDS). Because each samples’ paired reads were mapped to 
the same reference chromosomes and, thus, linked in the Geneious software to the same 
underlying reference sequence list in memory, Geneious automatically created unique 
variant tracks for each sample that could be compared, manipulated, and visualized 
simultaneously on a per-chromosome basis (see Figure 39). Some manual curation of these 
automated variant calls was performed in order to eliminate either conserved variants (as 
compared to the WT control sequence), variants called in uninteresting genomic regions 
(e.g. between coding sequences or within telomeric sequences), or variants called in 
regions of generally poor sequencing coverage.  
 
Figure 39. Visualizing variant calls across multiple samples simultaneously. 
An example multi-track visualization of variant calls across multiple sequenced 
samples (WT, SL6, SL7, SL8, SL11, SL12, SL13 and SL14). This example 
highlights a small portion of chromosome I (95,300…96,300) that includes the 
SAW1 gene. [A conserved polymorphism was observed in this gene across all 
samples (interval 95,694; A -> T; N -> I; P < 10-137).] In general, any conserved 
polymorphisms were noted and ultimately disregarded as true variants of interest. 
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The eight sequenced samples were originally mapped in error against the BY4741 
genome (the YKO deletion strain derived from and closely related to S288C) by request to 
The Sequencing Center (TSC). Because the yeast strains used in this study were derived 
from the W303 strain, this initial bioinformatics work performed by TSC was 
fundamentally inadequate at producing any useful variant call data. However, this work 
did provide insights into the genomic divergence of these yeast strains from 
BY4741/S288C. The average number of variants per chromosome from SL6, SL7, SL8, 
SL11, SL12, SL13, and SL14 were calculated. Chromosome XI (with 1,739 variants) was 
the most divergent and chromosome XVI (with 131 variants) was the most similar (see 
Figure 40). Ralser et al. (2012) reported similar results in their study on the ancestry and 
physiology of the W303 strain.      
 
Figure 40. Comparing sequenced chromosome similarity with the S288C 
genome. 
The average number of automated variant calls per chromosome were determined 
after mapping against the S288C genome. A significant number of automated 
variant calls (>8,000) were expected when mapping against the S288C genome. 
Chromosome XI (1,739 variants) was the most divergent and chromosome XVI 
(131 variants) was the most similar.       
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 The seven sequenced putative synthetic lethal samples yielded a total of 594 
variants of interest after manual curation of those automated variant calls when mapped 
against the correct reference genome (W303) (see Figure 41). Mapping against the wrong 
genome (S288C) produced an untenable average number of variant calls (13,659 ± 369) 
(see above Figure 40). However, mapping against the correct genome (W303) decreased 
the average number of automated variant calls significantly by ≈18.9× per sample (723 ± 
69). Manual curation of these automated W303 variant calls further reduced this list (85 ± 
31). 
  
Figure 41. The number of variants called per sequenced sample. 
Automated variant calls when mapped against the correct W303 genome (723 ± 
69). Manual curation of these automated W303 variant calls yielded even fewer 
variants of interest per sequenced sample (85 ± 31). Total variants of interest 
identified after manual curation: 594. N=7. 
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Mutant Protein Sequence Analysis Using PROVEAN 
 The list of identified variants was further evaluated using the public Protein 
Variation Effect Analyzer (PROVEAN) server hosted by the J. Craig Venter Institute 
(Choi & Chan, 2015). PROVEAN is a bioinformatics software tool for predicting whether 
an amino acid sequence variation impacts the underlying biological function of the mature 
protein. The automated PROVEAN workflow begins by first querying the NCBI non-
redundant (nr) protein database for related sequences using BLASTp (e-value cutoff = 0.1) 
and then clustering these sequences using CD-HIT (75% global sequence identity). The 
top 30 CD-HIT clusters are used as the “supporting sequence set” for computing delta 
alignment scores for each single or multiple amino acid variation (i.e. substitutions, 
insertions, or deletions) for each related sequence. The final PROVEAN score is an average 
of the per-cluster average delta alignment scores with larger clusters being weighted more 
than smaller clusters.  
The coding sequence (CDS) codon numbers and amino acid changes for each 
variant were exported from the Geneious assemblies and reformatted in the standard 
Human Genome Variation Society (HGVS) nomenclature (e.g. V251I, A174V, etc.). The 
wild-type amino acid sequence for each gene was obtained from SGD YeastMine and used 
as the query sequence for each PROVEAN job (Cherry et al., 2012). The predefined 
PROVEAN threshold score of -2.50 was used to initially qualify variants as either being 
deleterious (≤-2.50) or neutral (>-2.50). Because this predefined PROVEAN threshold 
score was originally calibrated by Choi and Chan (2015) to resolve the maximum 
separation between deleterious and neutral variants in human protein variants, the 
distribution of PROVEAN scores of essential yeast gene variants identified in this study 
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was further examined. The list of essential yeast genes was obtained from SGD and used 
to filter the list of identified variants for only those essential genes. Finally, these essential 
gene mutants were visually mapped using the chromoMap R package (Anand & Rodriguez 
Lopez, 2020) (see Figure 42). A total of 50 mutant essential genes were identified with 
PROVEAN scores less than the predefined PROVEAN baseline score (-2.50). Except for 
the wild-type, non-mutagenized control yeast strain (WT), all putative synthetic lethal 
mutants (SL6, SL7, SL8, SL11, SL12, SL13 and SL14) contained several mutant essential 
genes (7 ± 3) with PROVEAN scores at or below the baseline score (see Table 6). 
 
Figure 42. Mutant essential gene PROVEAN scores. 
PROVEAN scores for all mutant essential genes identified in this study (N=50) 
were visualized as a heatmap applied to each chromosome using the chromoMap 
package for the R programming language (Anand, 2019). Shades of red indicates a 
PROVEAN score lower (i.e. more “deleterious’) than the baseline score (-2.50).   
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Gene Ontology (GO) Enrichment Analysis 
 The curated lists of putative ecm14 synthetic lethal variants identified by whole-
genome sequencing for each sequenced sample (SL6, SL7, SL8, SL11, SL12, SL13, and 
SL14) were further filtered across a range of PROVEAN thresholds starting at -2.50 and 
decreasing in increments of 0.75 down to a final threshold of -6.25. Both the ‘GO Process’ 
and ‘GO Function’ ontology aspects were queried using the Saccharomyces genome 
database (SGD) GO Term Finder (v0.86, July 2020) and the resulting terms merged per 
sequenced sample (Ashburner et al., 2000; Boyle et al., 2004). Because several essential 
genes were found to be mutated at or below the baseline threshold of -2.50, a more stringent 
PROVEAN cutoff of -4.00 was chosen for the final GO analysis (see above Figure 42, see 
Table 6). However, GO Term Finder queries were performed across the entire range of 
PROVEAN thresholds. Additionally, the GO Term Finder input query form only supports 
selecting an enrichment p-value threshold below 0.01, 0.05, or 0.1 (the default is 0.01). 
However, because this is limitation solely in the GO Term Finder user interface and not in 
the underlying data processing pipeline, simply replacing ‘&pvalue=0.1’ with 
‘&pvalue=1’ in the resulting URL in the address bar forces the search to include all 
resulting GO ontology terms. These data were recorded in a master GO spreadsheet for 
easy filtering and sorting.  
Genes annotated by the SGD as interacting either physically or genetically with 
ADE3, ECM14, or URA3 were also used to query the SGD Go Term Finder. As before, 
both the ‘GO Process’ and ‘GO Function’ ontology aspects were queried and merged. 
These data were also recorded in the master GO spreadsheet. These additional GO analyses 
were performed in order to compare these interacting genes with those mutated in the 
105 
synthetic lethal assays, to further determine any likely relevance with these three plasmid-
borne fungal genes (ADE3, ECM14, or URA3). 
 Each merged GO dataset was further filtered for only those GO ontology terms with 
enrichment p-values ≤ 0.5. This further trimmed the list of ontology terms to be considered 
in a single-page visualization. The resulting terms were then grouped according to their 
association with ADE3, ECM14, and URA3 and then sorted within each group by ascending 
p-values. Any ontology terms not associated with these three genes were classified as ND, 
not determined, and sorted alphabetically. Finally, enrichment p-values were converted to 
-LOG10 values and these values plotted as a heatmap using conditional formatting across a 
linear red-white, largest-to-smallest color gradient (see Figure 43).  
 Little overlap was observed between GO terms for ADE3, ECM14, and URA3, 
suggesting that these genes have very distinct biochemical and biological roles. For 
ECM14, the top reported GO function and process terms, found to be enriched in this gene 
list compared with a list of all yeast genes (p<0.05), included terms such as vesicle-
mediated transport (GO:0016192), vesicle fusion (GO:0006906), lipid binding 
(GO:0008289), and organelle organization (GO:0006996) (see Figure 43). These terms 
are consistent with a secreted or secretory role for Ecm14 in cell wall maintenance. 
 For all putative synthetic lethal mutants except SL7 and SL13, some enrichment 
(although not always reaching significance, p < 0.05) was found for GO terms associated 
with ADE3 interacting genes. Very few of the GO terms identified for the remaining 
synthetic lethal gene mutations reached a p<0.05 level of significance. In some cases, 
mutations were identified in genes known to be synthetic lethal with ade3. For example, 
both SL6 and SL7 presented very consistently red synthetic lethal colonies; a mutation in 
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the SHM2 gene resulting in a D219N amino acid change was identified in both. Likewise, 
SL11 and SL14 contained mutations in the SHM2 gene, while SL13 contained a mutation 
in the SHM1 gene. Both the SHM1 and SHM2 genes are reported in the SGD to be synthetic 
lethals of the ade3 gene.   
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Figure 43. Gene Ontology (GO) functional enrichment analysis of interactors. 
(A) Genes annotated by the Saccharomyces genome database (SGD) as interacting 
either physically or genetically with ADE3, ECM14, or URA3 were analyzed by 
Gene Ontology (GO). Little overlap is observed between GO terms for these three 
genes. The heatmap represents P-values for enrichment of genes within particular 
GO classifications. Arrowhead next to heatmap scale bar indicates 0.05. Top 25 
GO terms are shown for ECM14 only. (B) GO analysis for genes identified by 
whole-genome sequencing as being mutated in the indicated synthetic lethal, and 
for which PROVEAN analysis surpassed a threshold of -4.0. GO terms are mapped 
to those identified in the SGD for ADE3, ECM14, and URA3 interactors. All others 




Fungi necessarily rely on a wide variety of hydrolases to break down and absorb 
the materials on which they grow. Few studies have examined carboxypeptidases 
expressed by fungi. Only two ascomycete metallocarboxypeptidases have been previously 
identified and characterized. Several publications have examined one CPA from 
Metarhizium anisopliae (Austin et al., 2011; Austin & Waugh, 2012; Joshi & St Leger, 
1999), while a second related CPA from Trichophyton rubrum had also been partially 
characterized (Zaugg et al., 2008). Both enzymes exhibited typical CPA-like substrate 
specificity. 
It is likely that Ecm14 is an inactive enzyme, or pseudoenzyme. Although it is 
difficult, if not impossible, to prove the absence of a function, previous studies have been 
unable to detect carboxypeptidase activity in S. cerevisiae Ecm14 using standard 
chromogenic assays, and this is consistent with the substitution of critical residues within 
the pseudoactive site of Ecm14. 
ECM14 was previously identified through transposon mutagenesis as a gene 
providing resistance to calcofluor white and thus implicated in cell wall maintenance 
(Lussier et al., 1997). This ECM14 mutant, in addition to being sensitive to calcofluor 
white, exhibited an increased mannose:glucose ratio and was sensitive to the effects of the 
aminoglycoside antibiotic hygromycin B and the glycolipid papulacandin B, thought to 
inhibit β1,3-glucan synthesis (Lussier et al., 1997). In this study of cell wall maintenance, 
two yeast strains with differing sensitivity to calcofluor white were used, and the ecm14 
mutant was only identified in one of these two screens. This differing sensitivity is 
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consistent with our observation of strain-specific sensitivities, as mild calcofluor white 
sensitivity was only detected in BY4741a cells grown long-term in one of two labs. 
An understanding of the subcellular or extracellular location of a protein such as 
Ecm14 can provide useful information regarding the biological function of the protein. 
Although Schott (2015) was unable to identify Ecm14 in the liquid growth media of S. 
cerevisiae cells expressing Ecm14-His6, this polyhistidine-tagged Ecm14 was secreted 
when expressed heterologously from Sf9 insect cells. Others have shown differing results 
regarding localization. One large-scale analysis of yeast GFP-fusion proteins found that 
Ecm14-GFP was localized to the yeast vacuole (Huh et al., 2003). A proteomic analysis of 
S. cerevisiae grown in biofilm-like mats identified Ecm14 as one of many proteins found 
in the extracellular matrix, but not secreted into the medium of a liquid culture (Faria-
Oliveira et al., 2015). These results suggest that Ecm14 likely functions within the 
extracellular matrix of yeast, maybe primarily under biofilm-like conditions, or possibly 
within the vacuole for the intracellular regulation of cell wall and extracellular matrix 
components. 
Ecm14 has been identified in studies of several pathogenic fungi in recent years, 
and these studies continue to point toward a function in cell wall/extracellular matrix 
remodeling. A C. albicans screen for genes involved in aggregate invasive growth, a 
process related to biofilm formation, identified an ECM14 mutant showing fewer 
aggregates than the wild-type (Chow et al., 2019). This hints at a role in aggregate invasion, 
although the equivalent experiment performed with an S. cerevisiae ecm14Δ mutant did 
not result in a phenotype (Chow et al., 2019), suggesting either a false positive in the first 
screen or the use of inappropriate conditions for this assay with S. cerevisiae. A 
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transcriptomics study of the plant pathogen V. dahliae showed that the expression of 
Ecm14, along with a variety of cell wall degrading hydrolases, was upregulated in response 
to exudates from V. dahliae-susceptible cotton roots (Zhang et al., 2020). This again points 
to a possible role for Ecm14 in invasion. Finally, a recent analysis of glycosylation in the 
plant pathogen M. oryzae showed that the glycosylation of Ecm14 is upregulated primarily 
during mycelial growth as compared with the conidia and appressoria stages (Chen et al., 
2020). It was proposed that many proteins differentially glycosylated during mycelial 
growth were involved in cell wall biogenesis and nutrient utilization (Chen et al., 2020).  
Schott (2015) found that Ecm14 expressed in S. cerevisiae was also glycosylated, although 
the function of this modification was not further examined. 
The above studies indicating a role for Ecm14 in fungal growth and pathogenesis 
lend support to this study in which Ecm14 is shown to be highly conserved across the 
ascomycete lineage (see Figure 45). These aspects of fungal growth are important to 
understand as we try to counteract the pathogenic effects of many fungi. An analysis of all 
reported interactions with ECM14 supports the likelihood that a functional secretory 
pathway and other aspects of organellar trafficking are required for Ecm14 function. 
Unfortunately, attempts to further identify redundant pathways through a synthetic lethal 
approach suggested that redundant pathways were many, such that a single-gene synthetic 
lethal clone from the analysis of nearly 30,000 mutants was unable to be isolated, or that 
Ecm14 was not required in the conditions and cells examined during these assays.  
It could be that a clear phenotype for S. cerevisiae ecm14 mutants has not yet been 
identified because most yeast that are used in the lab are unable to effectively form 
aggregates. Scientists have effectively selected against this phenotype to make yeast 
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genetics simpler. The data suggests that, while Ecm14 may not be required in many 
laboratory strains of S. cerevisiae, Ecm14 is a conserved and important pseudoenzyme 
within many fungal species that exists in zymogen form until activated by a trypsin-like 





Table 1. PCR primers used in this study. 
Name nt 
GC 
Sequence (5’ to 3’) 
% 
T7 20 40.0 TAATACGACTCACTATAGGG 
T3 21 42.9 GCAATTAACCCTCACTAAAGG 
ECM14_A 25 36.0 ATTTTAGTTCTTGTGGTGACAGCTT 
ECM14_D 25 36.0 AATCACTAAAAAGGAGATGAAGCCT 
ECM14_A-BamHI 35 37.1 (TATA)[GGATCC]ATTTTAGTTCTTGTGGTGACAGCTT 
ECM14_D-BamHI 35 37.1 (TATA)[GGATCC]AATCACTAAAAAGGAGATGAAGCCT 
ECM14_Internal 20 50.0 GCAGATAAATGATGGGCAGG 
Kan_C (KanC) 22 36.4 TGATTTTGATGACGAGCGTAAT 
ECM14_H69A-for 28 57.1 CACAGGTGGTATA{GC}TGCCAGAGAGTGG 
ECM14_H69A-rev 28 57.1 CCACTCTCTGGCA{GC}TATACCACCTGTG 
ECM14_H145A-for 30 43.3 GTATCGACATTGAT{GC}TTCCTTTGGTTTCC 
ECM14_H145A-rev 30 43.3 GGAAACCAAAGGAA{GC}ATCAATGTCGATAC 
ECM14_K270A-for 30 53.3 GGGCATTCCAGTTG{GC}ATTACGGGATACAG 
ECM14_K270A-rev 30 53.3 CTGTATCCCGTAAT{GC}CAACTGGAATGCCC 
ECM14_K270E-for 30 50.0 CTGTATCCCGTAATT{C}CAACTGGAATGCCC 
ECM14_K270E-rev 30 50.0 GGGCATTCCAGTTG{G}AATTACGGGATACAG 
() denote restriction enzyme sitting sequence. 
[] denote restriction enzyme recognition sequence. 
{} denote mutagenic substitution sites. 
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Table 2. Plasmids constructed and used in this study. 
Name Kb Insert Features Source Reference 





pRS316 4.9 -- 






pAG25 3.7 -- AmpR, NatMX, ORI 
Peter J. 
Lyons 
Goldstein et al., 
1999 
pSLS1 10.8 -- 
ADE3, AmpR, CEN4/ARS1, 
ORI, URA3, pGAL1  
Melanie J. 
Dobson 
Barbour et al., 
2000 
pRS316-NatMX 6.2 NatMX 
AmpR, CEN4/ARS1, LacZα, 
ORI, URA3 
This study -- 
pBluescript-ECM141 4.8 ECM14 AmpR, LacZα, ORI This study -- 
-H69A1 4.8 -H69A AmpR, LacZα, ORI This study -- 
-H145A1 4.8 -H145A AmpR, LacZα, ORI This study -- 
-K270A1 4.8 -K270A AmpR, LacZα, ORI This study -- 
-K270E1 4.8 -K270E AmpR, LacZα, ORI This study -- 
pSLS1-ECM141 12.7 ECM14 
ADE3, AmpR, CEN4/ARS1, 
ORI, URA3, pGAL1 
This study -- 
-H69A1 12.7 -H69A 
ADE3, AmpR, CEN4/ARS1, 
ORI, URA3, pGAL1 
This study -- 
-H145A1 12.7 -H145A 
ADE3, AmpR, CEN4/ARS1, 
ORI, URA3, pGAL1 
This study -- 
-K270A1 12.7 -K270A 
ADE3, AmpR, CEN4/ARS1, 
ORI, URA3, pGAL1 
This study -- 
-K270E1 12.7 -K270E 
ADE3, AmpR, CEN4/ARS1, 
ORI, URA3, pGAL1 
This study -- 








Table 3. Three conserved positions mutated in ECM14 using QuikChange SDM. 
Role (Position1) M14 MCPs ECM14 -H69A -H145A -K270E -K270A 







   



















1 Relative to the mature polypeptide sequence of bovine CPA1. 
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Table 4. Yeast strains used in this study. 
Name Background Genotype Source 
Y1239 -- 

















CM-1A_2 AF-1A (W303) 
MATα {ade2-1 ura3-1 leu2-3,-112 his3-11,-15     
trp1-1 ade3∆ ecm14::KanMX} 
This study 
CM-1D_3 AF-1D (W303) 
MATa {ade2-1 ura3-1 leu2-3,-112 his3-11,-15     
trp1-1 ade3∆ ecm14::KanMX} 
This study 
CM-1A_2[ECM14]1 AF-1A (W303) 
MATα {ade2-1 ura3-1 leu2-3,-112 his3-11,-15 trp1-1 
ade3∆ ecm14::KanMX} [pSLS1-ECM14]* 
This study 
CM-1D_3[ECM14]1 AF-1D (W303) 
MATa {ade2-1 ura3-1 leu2-3,-112 his3-11,-15 trp1-1 
ade3∆ ecm14::KanMX} [pSLS1-ECM14]* 
This study 
CM-1A[NAT] AF-1A (W303) 
MATα {ade2-1 ura3-1 leu2-3,-112 his3-11,-15 trp1-1 
ade3∆} [pRS316-NatMX] 
This study 
1 Both insert orientations were constructed. The minus orientation was used in this study. 
{ } denote genomic-based features. 
[ ] denote plasmid-based features. 
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Table 5. Whole-genome sequencing using the Illumina MiniSeq® platform. 
Sample Bases Read Paired Reads Matched Reads 
Read Length Coverage GC 
x̄ (σ) x̄ % 
WT 878,377,752 5,997,874 4,899,419 (81.7%) 146.4 (15.7) 56.8 41.0 
SL6 581,444,805 3,959,960 3,216,531 (80.6%) 146.8 (15.7) 36.9 41.0 
SL7 494,730,687 3,451,230 2,746,783 (79.6%) 143.3 (19.6) 31.6 40.8 
SL8 634,384,283 4,321,856 3,626,739 (83.9%) 146.8 (15.3) 42.5 40.5 
SL11 633,162,416 4,309,744 3,721,436 (86.3%) 146.9 (15.2) 43.5 40.4 
SL12 743,482,836 5,087,184 4,611498 (90.6%) 146.1 (16.2) 53.3 40.4 
SL13 618,472,666 4,215,912 3,744,904 (88.8%) 146.7 (16.1) 44.3 40.5 
SL14 561,659,729 3,869,674 3,400,631 (87.9%) 145.1 (17.9) 39.2 40.6 







Table 6. Mutant essential genes identified in this study. 
Gene/ORF Name SL Variant 
PROVEAN 
Gene/ORF Name SL Variant 
PROVEAN 
Score1 Score1 
ARC19 (YKL013C) 7 E37K -3.838 PRP8 (YHR165C) 6 E204K -3.563 
ARH1 (YDR376W) 14 S119N -3.000 PSE1 (YMR308C) 14 D324N -5.000 
ARP5 (YNL059C) 13 G129R -4.940 REA1 (YLR106C) 6 L2361F -2.526 
BRR2 (YER172C) 12 A2113T -3.080 RET3 (YPL010W) 12 G19R -7.279 
BRR2 (YER172C) 8 S51F -5.146 ROM2 (YLR371W) 13 A1293T -3.540 
CFT1 (YDR301W) 13 N1072Y -7.500 RPA135 (YPR010C) 12 P951L -9.250 
COP1 (YDL145C) 11 G54S -5.978 RPB2 (YOR151C) 12 C829Y -9.421 
CYR1 (YJL005W) 12 G1471D -5.887 RPG1 (YBR079C) 6 A582T -2.555 
EXO84 (YBR102C) 14 P92S -2.652 SEC7 (YDR170C) 8 S322F -2.719 
FHL1 (YPR104C) 11 T647M -5.400 SLY1 (YDR189W) 13 S91F -3.537 
GCD6 (YDR211W) 14 R120K -2.980 SLY1 (YDR189W) 13 S130L -5.365 
GUS1 (YGL245W) 8 A222T -4.000 SMC2 (YFR031C) 7 A168T -3.996 
ILV3 (YJR016C) 12 P148L -9.701 SMC3 (YJL074C) 14 A1141T -3.967 
ILV3 (YJR016C) 7 G454D -5.304 SOG2 (YOR353C) 13 G227E -6.911 
KIN28 (YDL108W) 13 E84K -3.989 SSC1 (YJR045C) 14 A281T -3.970 
MET30 (YIL046W) 11 G590S -3.015 STH1 (YIL126W) 13 T408I -5.967 
MOT1 (YPL082C) 11 P1265S -7.933 STT4 (YLR305C) 14 A662T -3.311 
MSS4 (YDR208W) 11 P432L -9.567 SUA5 (YGL169W) 12 A208V -4.000 
NET1 (YJL076W) 8 E107K -3.133 TAM41 (YGR046W) 8 G129S -3.200 
NFS1 (YCL017C) 12 V401M -2.647 TIF34 (YMR146C) 12 P143L -6.270 
NOP15 (YNL110C) 14 S131F -5.750 TOR2 (YKL203C) 11 P434L -6.408 
NOP8 (YOL144W) 13 R174S -3.733 TRL1 (YJL087C) 14 R352K -3.000 
PAN1 (YIR006C) 8 R635C -7.952 TRR1 (YDR353W) 12 G130C -8.827 
PCM1 (YEL058W) 11 G233D -6.965 TRS120 (YDR407C) 14 P935S -3.715 
PRP6 (YBR055C) 8 P734S -5.639 UTP20 (YBL004W) 13 D517N -3.428 




Figure 44. The functional rescue assay workflow. 
(1) A diploid yeast strain is produced by crossing a wild-type haploid [pRS316-
NatMX] strain with a haploid synthetically lethal strain (gene-y, ecm14::KanMX). 
Diploids are selected for by growth on YPD/G418/NTC. (2) Growth on SC+5FOA 
allows for selection against the now unnecessary pRS316-NatMX and pSLS1-
ECM14 plasmids. (3) Cells are transformed with the pSLS1 or pSLS1-ECM14 
plasmids followed by (4) random sporulation and germination of these haploid 




Figure 45. Ecm14 is conserved in Ascomycota, but not in other fungal phyla. 
BLASTp was performed with bovine CPA1 as the query sequence and all fungal 
sequences as the search set. 2068 sequences of 150 amino acids or longer that 
contained the majority of the carboxypeptidase domain were identified and aligned 
using Clustal Omega. The resulting tree is shown, containing three predominant 
groups consistent with CPB-like, CPA-like, and Ecm14-like properties. Sequences 
from basal fungi are shown in pink. CPB sequences from ascomycetes are shown 
in dark red, with co-clustering sequences lacking the required Asp at position 255 
shown in a lighter red. CPA-like sequences, mostly from ascomycetes, are shown 
in blue. Ecm14 sequences, all from ascomycetes, are shown in dark green, with a 
sister clade of Ecm14-like proteins from basidiomycetes, and with unique and 
conserved ‘active’ site residues, shown in cyan and light green. Ecm14 proteins are 





DIRECT SELECTION OF YEAST DIPLOIDS 
Subcloning the NatMX Allele From pAG25 into pRS316 
The original yeast strains used in this study are isogenic and, thus, lack 
complementary recessive auxotrophic markers typically used for the routine selection of 
diploids from mating reactions (see above Table 4). Furthermore, these autotrophies can 
impair yeast growth and interfere with downstream methods like sporulation (Sadowski et 
al., 2008). Thus, alternative methods for selecting diploids can be desirable. In order to 
facilitate both the direct selection and stable propagation of diploids strains produced in 
this study, an additional yeast plasmid harboring a unique drug-resistance marker was 
constructed. By mating haploid yeast strains that each harbor a unique drug-resistance 
marker (e.g. NatMX and KanMX), it is possible to directly select for diploids on media 
containing a combination of these two drugs (e.g. NTC and G418). Only those diploids 
containing both markers can survive on this selection media (see Figure 46).  
 
Figure 46. The direct selection of diploids using multiple drug-resistance markers. 
Mating haploid yeast strains that each harbor a unique drug-resistance marker 
produces diploids that can grow on media containing both drugs. Because the 
parental haploids each lack one of these drug-resistance markers, these haploids are 
unable to survive on this media. 
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The dominant NatMX allele from the pAG25 plasmid was subcloned into the yeast 
shuttle vector pRS316 (see above Table 2). The pAG25 plasmid alone is only useful as a 
template for PCR to create gene deletion cassettes and, thus, lacks the CEN4/ARS1 
sequences required for replication in yeast. An ample amount of both pAG25 and pRS316 
were thoroughly digested with BamHI and EcoRI to ensure adequate recovery yields for 
future downstream applications. 15 μl of either pAG25 or pRS316 was combined with 28 
μl of sterile Milli-Q water, 5 μl of CutSmart Buffer,1 μl of BamHI-HF enzyme, and 1 μl of 
EcoRI-HF enzyme. Both digestion reactions were allowed to incubate for 2 hours at 37°C. 
Both digestion reactions were subsequently electrophoresed in a 0.8% agarose gel (0.5 
μg/ml EtBr) for 60 minutes to allow for separation of the pAG25 (2,465 bp) and NatMX 
(1,239 bp) bands. 
The pRS316 and NatMX bands were both gel extracted using the modified protocol 
for large DNA fragments, ran in an additional 0.8% agarose gel (0.5 μg/ml EtBr), and 
quantified using ImageJ. The pRS316-NatMX ligation reaction was performed overnight 
at 16°C with a 1:3 vector-to-insert ratio. This ligation reaction contained 0.5 μl of pRS316-
BamHI-EcoRI (44.62 ng/μl, 0.014 pmol), 13 μl of NatMX-BamHI-EcoRI (2.68 ng/μl, 
0.043 pmol), 3.5 μl of sterile Milli-Q water, 2 μl of T4 DNA Ligase Buffer, and 1 μl of T4 
DNA Ligase. 
One 50-μl aliquot of Invitrogen Max Efficiency DH5α was slowly thawed on wet 
ice and gently mixed with 5 μl of the overnight pRS316-NatMX ligation reaction. This 
transformation mixture was incubated on wet ice for 30 minutes, heat shocked at 42°C for 
45 seconds, and returned to wet ice for 2 minutes. The transformation mixture was 
incubated for 60 minutes at 37°C in 450 μl of fresh SOC without ampicillin to allow for 
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adequate expression of the ampicillin resistance gene prior to plating. This outgrowth 
culture was subsequently plated on dry IPTG/X-Gal LB agar plates (250 μl/plate) with 
ampicillin and incubated at 37°C overnight for >20 hours. 
Four putative pRS316-NatMX colonies (white) were cultured overnight and 
miniprepped using the NID method and digested with BamHI-HF and EcoRI-HF at 37°C 
for 60 minutes. Each of these diagnostic digests included 5 μl of plasmid DNA, 12 μl of 
sterile Milli-Q water, 2 μl of CutSmart Buffer, and 1 μl of BamHI-HF enzyme. Each digest 
was ran in a 0.8% agarose gel (0.5 μg/ml EtBr) and imaged using the AlphaImager HP gel 
imaging system (see Error! Reference source not found.). Only those digests that clearly l
iberated both a pRS316 band (4.9-kb) and a NatMX band (1,239-bp) were considered for 
further interrogation. A map of the pRS316-NatMX plasmid was constructed using 
SnapGene (see Figure 48). Diploid selection using the pRS316-NatMX plasmid was 
demonstrated using the yeast strains relevant to this study (see Figure 49). 
 
Figure 47. Subcloning of NatMX from pAG25 into pRS316. 
The NatMX gene was subcloned from the pAG25 (3.7 kb) parent plasmid into the 
pRS316 (4.9 kb) destination vector. The pAG25 parent plasmid and pRS316 
destination vector were double digested with BamH1 and EcoRI. T4 DNA ligase 
was used to ligate the NatMX insert into pRS316. Four putative pRS316-NatMX 
preparations were digested with BamHI and EcoRI. Only those digests that clearly 
liberated both a pRS316 band (4.9 kb) and a NatMX band (1.2 kb) were considered 




Figure 48. Diagrams of the pAG25 plasmid, the pRS316 shuttle vector, and the 
recombinant pRS316-NatMX plasmid. 
(A) The pAG25 plasmid was the source of the NatMX expression cassette. (B) The 
pRS316 plasmid is able to replicate in both bacteria (high-copy) and yeast (single-
copy). (C) The recombinant pRS316-NatMX plasmid. Only plasmid features 




Figure 49. Selecting diploids using the pRS316-NatMX plasmid.  
A basic proof-of-concept demonstrating the direct selection of yeast diploids using 
two unique drug-resistance markers and selective growth media containing a 
combination of two drugs. Haploid control yeast (MATα and MATa) were streaked 
on this YPD+G418+NTC media. Diploids were mated by mixing both mating types 
on a YPD plate (without drugs) and incubating overnight at 30°C. This overnight 
mating reaction was resuspended in 1ml of sterile water, diluted 100X, and plated 
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